<SEC-DOCUMENT>0000883984-22-000026.txt : 20220420
<SEC-HEADER>0000883984-22-000026.hdr.sgml : 20220420
<ACCEPTANCE-DATETIME>20220420172420
ACCESSION NUMBER:		0000883984-22-000026
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220415
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20220420
DATE AS OF CHANGE:		20220420

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34634
		FILM NUMBER:		22839058

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>icui-20220415.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:b01f3e58-929d-44cf-82e3-9cd911bcc09b,g:6cae09ed-1c74-4bf1-a1a7-eb31dc8be467,d:216f780485744099b8332d218e44a2a3--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>icui-20220415</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM180L2ZyYWc6MTg5NGM2Yzc5N2QxNDExMDljNmM2MmU3YTdiNDA5Y2UvdGFibGU6YzllYmM0ODhkNzlmNGMwN2JjOTEwOTY1ZjI5NWQ2NjYvdGFibGVyYW5nZTpjOWViYzQ4OGQ3OWY0YzA3YmM5MTA5NjVmMjk1ZDY2Nl8wLTEtMS0xLTgwNzc3_d7195791-bf64-44a4-912c-aaa66e727eac">false</ix:nonNumeric><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM180L2ZyYWc6MTg5NGM2Yzc5N2QxNDExMDljNmM2MmU3YTdiNDA5Y2UvdGFibGU6YzllYmM0ODhkNzlmNGMwN2JjOTEwOTY1ZjI5NWQ2NjYvdGFibGVyYW5nZTpjOWViYzQ4OGQ3OWY0YzA3YmM5MTA5NjVmMjk1ZDY2Nl8xLTEtMS0xLTgwNzc3_eaac6acf-c2e8-4d63-a275-ff5842b7f307">ICU MEDICAL INC/DE</ix:nonNumeric><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM180L2ZyYWc6MTg5NGM2Yzc5N2QxNDExMDljNmM2MmU3YTdiNDA5Y2UvdGFibGU6YzllYmM0ODhkNzlmNGMwN2JjOTEwOTY1ZjI5NWQ2NjYvdGFibGVyYW5nZTpjOWViYzQ4OGQ3OWY0YzA3YmM5MTA5NjVmMjk1ZDY2Nl8yLTEtMS0xLTgwNzc3_abcf1d38-4590-4417-b292-41630defe589">0000883984</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="icui-20220415.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-15</xbrli:startDate><xbrli:endDate>2022-04-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i216f780485744099b8332d218e44a2a3_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;FORM&#160;<ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl81MTI_3c1b4608-b220-4105-80cf-aade9c6a1889">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl8yMjc_5251e59d-7c5b-46e0-a294-d89c9b649da4">April 15, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:477.75pt"><tr><td style="width:1.0pt"></td><td style="width:147.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:148.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:148.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6N2E0MGIwODI1ODQ5NDkzOWFmNDA5MmE1OWUwYzYyOTAvdGFibGVyYW5nZTo3YTQwYjA4MjU4NDk0OTM5YWY0MDkyYTU5ZTBjNjI5MF8wLTAtMS0xLTgwNzc3_827c546b-11ae-461e-9134-489b7c81e2ea">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6N2E0MGIwODI1ODQ5NDkzOWFmNDA5MmE1OWUwYzYyOTAvdGFibGVyYW5nZTo3YTQwYjA4MjU4NDk0OTM5YWY0MDkyYTU5ZTBjNjI5MF8wLTItMS0xLTgwNzc3_141dbbb9-86d2-43f5-969a-e02b05c50345">001-34634</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6N2E0MGIwODI1ODQ5NDkzOWFmNDA5MmE1OWUwYzYyOTAvdGFibGVyYW5nZTo3YTQwYjA4MjU4NDk0OTM5YWY0MDkyYTU5ZTBjNjI5MF8wLTQtMS0xLTgwNzc3_d14c148a-8713-4803-b9fa-6e623f6b30c4">33-0022692</ix:nonNumeric></span></td></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of incorporation) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.) </span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:396.00pt"><tr><td style="width:1.0pt"></td><td style="width:100.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:112.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTAtMS0xLTgwNzc3_3c777f01-5fed-4ec5-8fb9-8fcb52f8cade">951 Calle Amanecer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTItMS0xLTgwNzc3_507f8283-8f08-44a5-a19d-350ecf989292">San Clemente</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTQtMS0xLTgwNzc3_3486ceff-d1f9-4338-96e3-7c2682dc55da">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTYtMS0xLTgwNzc3_c7288030-39c1-4139-a214-af4a90edaba7">92673</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl81MTQ_c2a3f782-e98b-4fa2-9454-11bf31ec4d74">949</ix:nonNumeric>) <ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl81MTU_1b49bf8f-64ad-4a5c-ad55-9b25a13f7f8f">366-2183</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:490.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl8xLTEtMS0xLTgwNzc3_4b576feb-7517-4d17-8f83-3ecfe4181c36">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl8yLTEtMS0xLTgwNzc3_b2ca1ca8-d5dd-4fe5-a75e-a08016aa4c9b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl8zLTEtMS0xLTgwNzc3_24c3f917-6994-4a6f-875d-323ffe77c287">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl80LTEtMS0xLTgwNzc3_987fc2dc-86f6-4e1c-9a5e-de5761087f2b">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:34.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZjYwZjIzYjQyYTk5NGZjZjlhNTEzNzAwYWFlNTY3MmMvdGFibGVyYW5nZTpmNjBmMjNiNDJhOTk0ZmNmOWE1MTM3MDBhYWU1NjcyY18xLTAtMS0xLTgwNzc3_6e2b9e54-5dd9-4205-851f-e9f73e640303">Common stock, par value $0.10 per share</ix:nonNumeric></span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZjYwZjIzYjQyYTk5NGZjZjlhNTEzNzAwYWFlNTY3MmMvdGFibGVyYW5nZTpmNjBmMjNiNDJhOTk0ZmNmOWE1MTM3MDBhYWU1NjcyY18xLTEtMS0xLTgwNzc3_590edd95-ed43-4d51-93ca-5063e09c7e2c">ICUI</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZjYwZjIzYjQyYTk5NGZjZjlhNTEzNzAwYWFlNTY3MmMvdGFibGVyYW5nZTpmNjBmMjNiNDJhOTk0ZmNmOWE1MTM3MDBhYWU1NjcyY18xLTItMS0xLTgwNzc3_8ed502d6-e699-45aa-9e1e-0cd3839fb16b">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Global Select Market)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:480.75pt"><tr><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:124.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:124.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:202.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:35pt"><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MDQ2ZDk2YjgzNzg0NGQ1YjkwOTBlMDY2ZTcwODdkZWMvdGFibGVyYW5nZTowNDZkOTZiODM3ODQ0ZDViOTA5MGUwNjZlNzA4N2RlY18xLTItMS0xLTgwNzc3_bc4c180f-ddb7-41b2-9d93-0e56df5bec3d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:50pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i216f780485744099b8332d218e44a2a3_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i216f780485744099b8332d218e44a2a3_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02      Election of Director; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2022, ICU Medical, Inc. (the &#8220;Company&#8221;) entered into an Amended and Restated Employment Agreement with Vivek Jain (the &#8220;Amended Employment Agreement&#8221;), the Company&#8217;s Chief Executive Officer. The Amended Employment Agreement is effective as of March 1, 2022 and will continue until March 1, 2025, unless earlier terminated, and supersedes the prior Amended and Restated Executive Employment Agreement, dated as of May 8, 2017 (the &#8220;Prior Employment Agreement&#8221;). The term of the Amended Employment Agreement is subject to automatic one-year renewal terms unless either the Company or Mr. Jain gives written notice of termination at least 60 days prior to the end of the applicable term.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions of the Amended Employment Agreement are the same as in the Prior Employment Agreement, except that:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under the Amended Employment Agreement, Mr. Jain is entitled to receive an annual base salary of $775,000.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the event that Mr. Jain&#8217;s employment is terminated by the Company without &#8220;cause&#8221;, by Mr. Jain for &#8220;good reason&#8221;, by reason of a non-renewal of the term by the Company and Mr. Jain is willing and able, at the time of such non-renewal, to continue performing services under the Amended Employment Agreement or by reason of Mr. Jain&#8217;s death or &#8220;disability&#8221; (each, as defined in the Amended Employment Agreement as an &#8220;involuntary termination&#8221;), subject to delivery and non-revocation of a general release of claims in favor of the Company, Mr. Jain&#8217;s then-outstanding Company equity-based awards granted between January 1, 2020 to December 31, 2021 will vest in full (with all performance goals or other vesting criteria deemed to be achieved at target levels).</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the event Mr. Jain experiences an &#8220;involuntary termination&#8221; during the period beginning on and including sixty days prior to the date of a &#8220;change in control&#8221; (as defined in the Amended Employment Agreement) and ending on and including the two-year anniversary of the date of a change in control, Mr. Jain will receive the same accelerated vesting as described above, and all of his then-outstanding Company equity-based awards that vest solely based on Mr. Jain&#8217;s continued service will also vest in full.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summary of the material terms of the Amended Employment Agreement is qualified in its entirety by the full terms and conditions of the Amended Employment Agreement, a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.106%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101_41522.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Executive Employment Agreement, dated as of April 15, 2022, by and between ICU Medical, Inc. and Vivek Jain.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.242%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICU MEDICAL, INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 20, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian M. Bonnell</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101_41522.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i31a8eda2403f43e88677b0adec8a33e8_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit 10.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">AMENDED AND RESTATED </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Amended and Restated Executive Employment Agreement (the &#8220;Agreement&#8221;) is entered into effective as of this 1st day of March, 2022 (the &#8220;Effective Date&#8221;) by and between ICU Medical, Inc., a Delaware Corporation (the &#8220;Company&#8221;) and Vivek Jain (&#8220;Executive&#8221;) (collectively, the &#8220;parties&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Company and Executive have entered into that certain Amended and Restated Executive Employment Agreement, dated as of May 8, 2017 (the &#8220;Prior Agreement&#8221;) which sets forth the terms and conditions of Executive&#8217;s employment by the Company&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Company and Executive desire to amend and restate the Prior Agreement, on the terms and subject to the conditions set forth in this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">NOW, THEREFORE, in consideration of the covenants, promises and representations set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:28.34pt">Position and Responsibilities</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Position.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> As of the Effective Date, Executive shall continue to be employed by the Company to render services to the Company in the position of Chief Executive Officer of the Company. Executive shall report directly to the Board of Directors of the Company (the &#8220;Board&#8221;), shall be an executive officer of the Company, shall have all authorities, duties and responsibilities customarily exercised by an individual serving as the chief executive officer of an entity of the size and nature of the Company, and shall be assigned no duties or responsibilities that are materially inconsistent with, or that materially impair his duty to discharge, the foregoing duties and responsibilities.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Board Membership.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Executive currently is a member and Chairman of the Board.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">No Conflict. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive represents and warrants that Executive&#8217;s execution of this Agreement, continued employment with the Company, and the performance of Executive&#8217;s proposed duties under this Agreement shall not violate any legally enforceable obligations Executive may have to any other employer, person or entity, including any obligations with respect to proprietary or confidential information of any other person or entity.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Period of Employment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The term of Executive&#8217;s employment by the Company under this Agreement will be for a term (the &#8220;Period of Employment&#8221;) that begins on the Effective Date, and will continue until the third anniversary of the Effective Date (the &#8220;Initial Termination Date&#8221;), unless earlier terminated pursuant to Section III hereof. If not previously terminated, the Period of Employment shall automatically be extended for one (1) additional year </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">on the Initial Termination Date and on each subsequent anniversary of the Initial Termination Date (each such extension, a &#8220;Renewal Term&#8221;), unless either party elects not to so extend the Employment Period by notifying the other party, in writing, of such election (a &#8220;Non-Renewal&#8221;) at least sixty (60) days prior to the last day of the then-current Period of Employment.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25.67pt">Duties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> During the Period of Employment, Executive shall devote all of Executive&#8217;s business time, energy, business judgment, knowledge and skill and Executive&#8217;s best efforts to the performance of Executive&#8217;s duties with the Company, provided that the foregoing shall not prevent Executive from (i) serving on the boards of directors of non-profit organizations with the prior written approval of the Board, (ii) participating in charitable, civic, educational, professional, community or industry affairs, and (iii) managing Executive&#8217;s passive personal investments so long as such activities in the aggregate do not materially interfere or materially conflict with Executive&#8217;s duties hereunder or create a potential business or fiduciary conflict.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:23.68pt">Compensation and Benefits</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Base Salary.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> In consideration of the services to be rendered under this Agreement, during the Period of Employment, the Company shall pay Executive a salary at the rate of seven hundred and seventy-five thousand Dollars ($775,000) per year (&#8220;Base Salary&#8221;). The Base Salary shall be paid in accordance with the Company&#8217;s regularly established payroll practice. Executive&#8217;s Base Salary shall be adjusted annually upward (but not downward) as determined by the Board or the Compensation Committee of the Board (the &#8220;Compensation Committee&#8221;). Effective as of the date of each such adjustment, the Base Salary as so changed shall be considered the new Base Salary for all purposes of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">&#91;Intentionally Omitted.&#93;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Incentive Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. For each calendar year during which this Agreement is in effect, Executive shall participate in an annual bonus plan of the Company pursuant to which Executive&#8217;s target bonus opportunity shall not be less than one hundred percent (100%) of Executive&#8217;s Base Salary (the &#8220;Target Bonus&#8221;). The actual bonus paid may be higher or lower than the Target Bonus for over-or under-achievement of Company and individual objectives, with such individual objectives to be mutually agreed upon by the Board or Compensation Committee, and Executive. The Target Bonus will be subject to annual adjustment by the Board or the Compensation Committee, in its sole discretion&#59; provided, however, that Executive&#8217;s Target Bonus may not be decreased without Executive&#8217;s advance written consent. Executive must remain employed through the end of the fiscal year to which the Target Bonus relates in order to be eligible to receive a bonus for such year. Any bonus earned by Executive during the Period of Employment shall be paid to him as soon as reasonably practicable after the end of the year for which it is earned, but in no event later than March 15 of the year following the year for which it is earned.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Annual Equity Awards. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive shall be considered for annual equity incentive awards under any applicable plans adopted by the Company during the Period of Employment for which executives are generally eligible. Any equity awards for Executive shall be subject to the review and approval of the Board or the Compensation Committee, in its sole and absolute discretion, and shall be made consistent with past Company practice with respect to CEO level awards. The ultimate level of Executive&#8217;s participation in any such plans shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">determined in the sole discretion of the Board or the Compensation Committee from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Benefits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">During the Period of Employment, Executive shall be eligible to participate in the benefit plans made generally available by the Company to similarly-situated executives (including, but not limited to, 401(k) plans, nonqualified deferred compensation plans, and any medical, dental, vision, life insurance, disability, or fringe benefit plans).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25.67pt">Vacation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> During the Period of Employment, Executive shall be entitled to vacation in accordance with the Company&#8217;s vacation policy in place for executives of the Company, as the same that may be in effect from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:23.67pt">Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Company shall reimburse Executive for reasonable travel, lodging, entertainment, meal and other business expenses incurred in the performance of Executive&#8217;s duties hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:23.67pt">Legal Fees.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Company shall pay all legal fees and charges of counsel that Executive directly or indirectly incurs in connection with negotiating, documenting, implementing and the ability to accept the Agreement, up to a maximum of $10,000 which shall be paid no later than thirty (30) days after presentation of an acceptable invoice for such fees and&#47;or charges. Executive agrees to submit appropriate documentation to the Company reflecting such fees and&#47;or charges no later than December 31, 2022.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.02pt">At&#8209;Will Employment&#59; Termination of employment</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">At&#8209;Will Employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Executive&#8217;s employment with the Company shall be &#8220;at&#8209;will&#8221; at all times, meaning that either Executive or the Company shall be entitled to terminate Executive&#8217;s employment with the Company at any time, without any advance notice, for any reason or no reason at all, notwithstanding anything to the contrary contained in or arising from any statements, policies or practices of the Company relating to the employment, discipline or termination of its employees. Upon and after such termination, all obligations of Executive and the Company under this Agreement shall cease, except as otherwise provided herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Termination by the Company or by Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Period of Employment, Executive&#8217;s employment by the Company, and the Period of Employment, may be terminated at any time by the Company&#58; (i) with Cause (as defined in Section III.F and in compliance with the Notice of Termination conditions below), (ii) without Cause, (iii) in the event that Executive has a Disability (as defined in Section III.F) or (iv) if Executive&#8217;s employment with the Company is terminated due to the expiration of the Period of Employment (including a Renewal Term). Executive&#8217;s employment shall terminate automatically upon Executive&#8217;s death during the Period of Employment. The Company shall pay to Executive&#8217;s spouse, beneficiaries or estate, as required by the terms of Executive&#8217;s will as instructed by the executor of Executive&#8217;s estate, any compensation then due and owing.  Subject to Section III.D., thereafter all obligations of the Company under this Agreement shall cease. Nothing in this Section shall affect any entitlement of Executive&#8217;s heirs or devisees to the benefits of any life insurance plan or other applicable benefits.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Termination by Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Period of Employment, Executive&#8217;s employment by the Company, and the Period of Employment, may be terminated by notice to the Company which, to the extent such termination is for Good Reason (as defined in Section III.F), shall comply with the Notice of Termination conditions below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Benefits upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If Executive&#8217;s employment with the Company is terminated during the Period of Employment for any reason by the Company or by Executive (in any case, the date that Executive&#8217;s employment by the Company terminates is referred to as the &#8220;Severance Date&#8221;), the Company shall have no further obligation to make or provide to Executive, and Executive shall have no further right to receive or obtain from the Company, any payments or benefits except as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">The Company shall pay Executive (or, in the event of his death, Executive&#8217;s spouse, beneficiaries or estate, as required by the terms of Executive&#8217;s will as instructed by the executor of Executive&#8217;s estate) any Accrued Obligations (as defined in Section III.F) within ten (10) days after the Severance Date (or such earlier date as may be required by applicable laws)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">If, during the Period of Employment, Executive&#8217;s employment with the Company terminates as a result of an Involuntary Termination (as defined in Section III.F) (other than a CIC Termination), then, subject to Executive&#8217;s compliance with the obligations in Section III.D.4 hereof, Executive shall be entitled to the following benefits&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">The Company shall pay Executive a lump sum payment in cash equal to the sum of (x) one and a half (1.5) times the sum of (i) his Base Salary (as in effect immediately prior to the Involuntary Termination and disregarding any reduction in Base Salary that would give rise to Executive&#8217;s right to terminate for Good Reason) and (ii) the Target Bonus for the year of termination assuming all applicable performance goals and all applicable conditions to receiving such Target Bonus for the year are 100% satisfied (the &#8220;Cash Severance&#8221;) and (y) the prorated portion of Executive&#8217;s cash performance bonus for the year in which the Severance Date occurs, based on the actual achievement of applicable performance goals or objectives as determined in the same manner as such achievement is determined generally for the Company&#8217;s senior executives, without regard to the fact or timing of Executive&#8217;s termination of employment, and pro-rated based on the number of days during such year that Executive was employed (the &#8220;Bonus Severance&#8221;). Subject to Annex A, the Cash Severance payment will be made in a single lump sum on the sixtieth (60th) day following the Severance Date, and the Bonus Severance will be paid in a single lump-sum payment on the date on which annual bonuses are paid to the Company&#8217;s senior executives generally for such year, but in no event later than March 15th of the calendar year immediately following the calendar year in which the Severance Date occurs, with the actual date within such period determined by the Company in its sole discretion.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">Each equity award granted to Executive between January 1, 2020 and December 31, 2021 that is then-outstanding shall vest in full (which, in the case of any outstanding Company equity award that vests in whole or in part on the basis of achievement of performance goals, shall be determined as if performance were achieved at 100% of targeted performance) (and, if applicable, become exercisable) upon the effectiveness of the Release (as defined in Section III.D.4). In addition, all of Executive&#8217;s outstanding Company stock options shall remain exercisable, to the extent vested, for a period of three (3) years following the Severance Date, but in no event later than the maximum term&#47;expiration date of the applicable option.  Each other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">then-outstanding Company equity-based award held by Executive as of the Severance Date shall be treated in accordance with the applicable award agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">Subject to the requirements of the Code, if Executive properly elects health care continuation coverage under the Company&#8217;s group health plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), to the extent that Executive is eligible to do so, then the Company shall directly pay or, at its election, reimburse Executive for COBRA premiums for Executive and Executive&#8217;s covered dependents (in an amount determined based on the same benefit levels as would have applied if Executive&#8217;s employment had not been terminated based on the Executive&#8217;s elections in effect on the Date of Termination) until the earlier of the end of the month in which the 18-month anniversary of the Severance Date occurs or the date Executive becomes eligible for healthcare coverage under a subsequent employer&#8217;s health plan (the &#8220;COBRA Period&#8221;).  Notwithstanding the foregoing, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Code Section 409A under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation, Section 2716 of the Public Health Service Act or the Patient Protection and Affordable Care Act), then, in either case, an amount equal to each remaining Company reimbursement shall thereafter be paid to Executive in substantially equal monthly installments over the COBRA Period (or the remaining portion thereof).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">If, during the Period of Employment, Executive experiences a CIC Termination, then, subject to Executive&#8217;s compliance with the obligations in Section III.D.4 hereof, and instead of the severance payments and benefits set forth in Section III.D.2, the Company shall pay or provide to Executive, as applicable, all of the severance payments and benefits set forth in subsections (a), (b) and (c) of Section III.D.2, with the following modifications&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">subsection (a)(x) of Section III.D.2 shall be replaced with the following&#58; &#8220;two (2) times the sum of (i) his Base Salary (as in effect immediately prior to the Involuntary Termination and disregarding any reduction in Base Salary that would give rise to Executive&#8217;s right to terminate for Good Reason) and (ii) the Target Bonus for the year of termination assuming all applicable performance goals and all applicable conditions to receiving such Target Bonus for the year are 100% satisfied (the &#8220;Cash Severance&#8221;)&#59;&#8221;&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">the first sentence of subsection (b) of Section III.D.2 shall be replaced with the following&#58; &#8220;&#91;e&#93;ach then-outstanding Time-Based Equity Award held by Executive as of the Severance Date, and each other equity award granted to Executive between January 1, 2020 to December 31, 2021, including any then-outstanding Company equity award that vests in whole or in part on the basis of the achievement of performance goals, shall vest in full (which, in the case of any outstanding Company equity award that vests in whole or in part on the basis of achievement of performance goals, shall be determined as if performance were achieved at 100% of targeted performance) (and, if applicable, become exercisable) upon the effectiveness of the Release (as defined in Section III.D.4).&#8221;.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:27pt">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Any and all amounts payable and benefits or additional rights provided pursuant to Section III.D.2 or Section III.D.3 shall only be payable if Executive delivers to the Company and does not revoke the general release of claims in favor of the Company set forth in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Exhibit A (the &#8220;Release&#8221;). Such Release shall be executed and delivered (and no longer subject to revocation, if applicable) within sixty (60) days following termination.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Exclusive Remedy&#59; No Mitigation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">Executive agrees that the payments and benefits contemplated by Section III.D (and any applicable acceleration of vesting of an equity-based award in accordance with the terms of such award in connection with the termination of Executive&#8217;s employment) shall constitute the exclusive and sole remedy for any termination of his employment and Executive covenants not to assert or pursue any other remedies, at law or in equity, with respect to any termination of employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">Executive shall not be required to mitigate the amount of any payment or benefit contemplated by Section III.D, nor shall any such payment or benefit be reduced by any earnings or benefits that Executive may receive from any other source.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:7.67pt">Certain Defined Terms.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Accrued Obligations&#8221; means&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">any Base Salary, bonus or other amounts that had been earned and accrued but had not yet been paid (including accrued and unpaid vacation time) on or before the Severance Date&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">any reimbursement due to Executive pursuant to Section II.G for expenses incurred by Executive on or before the Severance Date.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Cause&#8221; shall mean&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">Executive&#8217;s gross neglect and willful and repeated failure to substantially perform his assigned duties, which failure is not cured within thirty (30) days after a written demand for substantial performance is received by Executive from the Board which identifies the manner in which the Board believes Executive has not substantially performed Executive&#8217;s duties&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">Executive&#8217;s engagement in illegal conduct or gross misconduct which is materially and demonstrably injurious to the Company&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">Executive&#8217;s conviction of, or plea of no contest to, a felony or a crime involving fraud, embezzlement, or theft&#59; or </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">Executive&#8217;s improper and willful disclosure of the Company&#8217;s confidential or proprietary information where such disclosure causes (or should reasonably be expected to cause) significant harm to the Company.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Change in Control&#8221; shall mean&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a &#8220;Person&#8221;) of beneficial ownership of any capital stock of the Company if, after such acquisition, such Person beneficially owns (within the meaning of Rule 13d-3 promulgated under the Exchange Act) 50% or more of either (i) the then-outstanding shares of common stock of the Company (the &#8220;Outstanding Company Common Stock&#8221;) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;Outstanding Company Voting Securities&#8221;)&#59; provided, however, that for purposes of this subsection, the following acquisitions shall not constitute a Change in Control&#58; (i) any acquisition from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (iv) any acquisition by any corporation pursuant to a transaction which complies with all of clauses (i), (ii) and (iii) of subsection (c) of this section&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">individuals who, as of the date hereof, constitute the members of the Board (the &#8220;Incumbent Directors&#8221;) ceasing for any reason to constitute at least a majority of the Board&#59; provided, however, that any individual becoming a director subsequent to the date hereof whose election or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least a majority of the Incumbent Directors then in office shall be deemed to be an Incumbent Director (except that this proviso shall not apply to any individual whose initial election as a director occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">the consummation of a reorganization, merger or consolidation involving the Company or a sale or other disposition of all or substantially all of the assets of the Company (a &#8220;Business Combination&#8221;), unless, immediately following such Business Combination, each of the following three conditions is satisfied&#58; (i) all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, respectively, of the resulting or acquiring corporation in such Business Combination (which shall include, without limitation, a corporation which as a result of such transaction owns the Company or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries)(such resulting or acquiring corporation is referred to as the &#8220;Acquiring Corporation&#8221;) in substantially the same proportions, relative to one another, as their ownership, immediately prior to such Business Combination, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively, (ii) no Person (excluding the Acquiring Corporation or any employee benefit plan (or related trust) maintained or sponsored by the Company or the Acquiring Corporation) beneficially owns, directly or indirectly, 50% or more of the then-outstanding shares of common stock of the Acquiring Corporation, or of the combined voting power of the then-outstanding voting securities of such corporation (except to the extent that such ownership existed prior to the Business Combination) and (iii) a majority of the members of the board of directors of the Acquiring Corporation were Incumbent Directors at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination&#59; or</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">approval of the stockholders of the Company of a complete liquidation or dissolution of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any payments to Executive (or portion of any payments) under this Agreement that provides for the deferral of compensation that is subject to Section 409A of the Code, to the extent required to avoid the imposition of additional taxes under Section 409A of the Code, the transaction or event described in subsection (a), (b), (c) or (d) with respect to such payments to Executive (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such payments if such transaction also constitutes a &#8220;change in control event,&#8221; as defined in Treasury Regulation Section 1.409A-3(i)(5).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;CIC Termination&#8221; shall mean an Involuntary Termination that occurs during the period beginning on and including sixty (60) days prior to the date of a Change in Control and ending on and including the two-year anniversary of the date of a Change in Control.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Disability&#8221; or &#8220;Disabled&#8221; shall mean Executive&#8217;s absence from the full-time performance of Executive&#8217;s duties with the Company for 180 consecutive calendar days as a result of incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to Executive or Executive&#8217;s legal representative.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Good Reason&#8221; shall mean the occurrence, without Executive&#8217;s written consent, of any of the events or circumstances set forth in clauses (a) through (e) below. Notwithstanding the occurrence of any such event or circumstance, such occurrence shall not be deemed to constitute Good Reason if, prior to the Date of Termination specified in the Notice of Termination given by Executive in respect thereof, such event or circumstance has been fully corrected and Executive has been reasonably compensated for any losses or damages resulting therefrom&#59; provided that such right of correction by the Company shall only apply to the first Notice of Termination for Good Reason given by Executive&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">any material diminution in Executive&#8217;s duties, authority or responsibilities (including reporting responsibilities) which, if the securities of the successor in the Change in Control are publicly traded on an established securities market (within the meaning set forth in Treasury Regulation 1.897-1(m)), shall include, without limitation the failure to appoint Executive as the Chief Executive Officer of the successor following the occurrence of the Change in Control and, as a result, failure for Executive to continue to have the duties, authority and responsibilities customarily exercised by an individual serving as the chief executive officer of an entity of the nature of the Company&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">a material reduction in Executive&#8217;s Base Salary&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">a requirement Executive report to a corporate officer or employee instead of reporting directly to the Board&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">a material change by the Company (or a successor, if appropriate) in the location at which Executive performs Executive&#8217;s principal duties for the Company to a new location that is either (i) more than 30 miles from the location at which Executive performs his principal duties for the Company immediately prior to such change, and which results in a material </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">increase in Executive&#8217;s daily commuting distance (by way of example, an increase in Executive&#8217;s one way commute by more than 30 miles would be considered a material increase in Executive&#8217;s daily commuting distance)&#59; or (ii) a requirement by the Company that the travel on Company business (more than 30 miles from the location at which Executive performs his principal duties for the Company) to a materially greater extent than required immediately prior to such requirement&#59; or</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">any material breach by the Company of this Agreement, including any intentional or commercially unreasonable failure of the Company to pay or provide to Executive any material portion of Executive&#8217;s compensation or benefits due under this Agreement or any other material compensation or benefit plan or program within seven days of the date such compensation or benefits are due.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Involuntary Termination&#8221; shall mean (a) a termination of Executive&#8217;s employment with the Company for Good Reason, (b) a termination of Executive&#8217;s employment by the Company without Cause or (c) a termination of Executive&#8217;s employment with the Company by reason of a Non-Renewal of the Period of Employment by the Company and Executive is willing and able, at the time of such Non-Renewal, to continue performing services on the terms and conditions set forth herein during the Renewal Term. For purposes of clarity, the term Involuntary Termination also includes a termination of Executive&#8217;s employment due to Executive&#8217;s death or Disability.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">As used herein, &#8220;Notice of Termination&#8221; shall mean written notice to the other party hereto for any termination of Executive&#8217;s employment by the Company for Cause or by Executive for Good Reason, given in accordance with Section X. Any Notice of Termination shall&#58; (i) indicate the specific termination provision (if any) of this Agreement relied upon by the party giving such notice&#59; (ii) to the extent applicable, set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination for Executive&#8217;s employment under the provision so indicated and (iii) specify the Date of Termination (as defined below). The date on which an employment termination becomes effective (the &#8220;Date of Termination&#8221;) shall be the close of business on the date specified in the Notice of Termination (which date shall be 30 days after the date of delivery of such Notice of Termination). In addition, the following terms and conditions apply to the Notice of Termination, as applicable&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">The failure by Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the Company, respectively, to assert any such fact or circumstance in enforcing Executive&#8217;s or the Company&#8217;s right hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">Any Notice of Termination for Cause given by the Company must be given within sixty (60) days of the occurrence of the event(s) or circumstance(s) which constitute(s) Cause. Prior to any Notice of Termination for Cause being given (and prior to any termination for Cause being effective), Executive shall be entitled to a hearing before the Board at which Executive may, at Executive&#8217;s election, be represented by counsel and at which he shall have a reasonable opportunity to be heard. Such hearing shall be held with not less than fifteen (15) days&#8217; prior written notice to Executive stating the Board&#8217;s intention to terminate Executive for Cause and stating in detail the particular event(s) or circumstance(s) which the Board believes constitutes Cause for termination.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.7pt">Any Notice of Termination for Good Reason given by Executive must be given within sixty (60) days of the initial occurrence of the event(s) or circumstance(s) which constitute Good Reason.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">&#8220;Time-Based Equity Award&#8221; shall mean a Company equity-based award which vests based solely on Executive&#8217;s continued service with the Company or any subsidiary or the lapse of time.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.68pt">CHANGE IN CONTROL</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.34pt">Limitation on Payments. In the event that any of the payments or benefits provided for in this Agreement or otherwise (i) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code, and (ii) but for this Section IV.A, would be subject to the excise tax imposed by Section 4999 of the Code, then Executive&#8217;s payments or benefits under this Agreement or otherwise will be either&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">delivered in full, or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">delivered as to such lesser extent which would result in no portion of such payments or benefits being subject to excise tax under Section 4999 of the Code,</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999 of the Code, results in the receipt by Executive on an after-tax basis of the greatest amount of payments and benefits, notwithstanding that all or some portion of such payments or benefits may be taxable under Section 4999 of the Code. Unless the Company and Executive otherwise agree in writing, any determination required under this Section IV.A will be made in writing by the Company&#8217;s independent public accountants at least ten (10) days prior to the date of the Change in Control (the &#8220;Accountants&#8221;), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section IV.A, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section IV.A. The Company will bear all fees and costs payable to the Accountants in connection with any calculations contemplated by this Section IV.A. Any reduction made pursuant to this Section IV.A shall be made in accordance with the following order of priority&#58; (i) stock options whose exercise price exceeds the fair market value of the optioned stock (&#8220;Underwater Options&#8221;), (ii) Full Credit Payments (as defined below) that are payable in cash, (iii) non-cash Full Credit Payments that are taxable, (iv) non-cash Full Credit Payments that are not taxable (v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made pro-rata in the event payments or benefits are owed at the same time). &#8220;Full Credit Payment&#8221; means a payment, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">distribution or benefit, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, that if reduced in value by one dollar reduces the amount of the parachute payment (as defined in Section 280G of the Code) by one dollar, determined as if such payment, distribution or benefit had been paid or distributed on the date of the event triggering the excise tax. &#8220;Partial Credit Payment&#8221; means any payment, distribution or benefit that is not a Full Credit Payment. In no event shall Executive have any discretion with respect to the ordering of payment reductions.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Termination Obligations</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Return of Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Executive agrees that all property (including without limitation all equipment, tangible proprietary information, documents, records, notes, contracts and computer-generated materials) furnished to or created or prepared by Executive incident to Executive&#8217;s employment belongs to the Company and shall be promptly returned to the Company upon termination of Executive&#8217;s employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Resignation and Cooperation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Upon termination of Executive&#8217;s employment, Executive shall be deemed to have resigned from all offices and directorships then held with the Company. Following any termination of employment, Executive shall cooperate with the Company in the winding up of pending work on behalf of the Company and the orderly transfer of work to other employees. Executive shall also cooperate with the Company in the defense of any action brought by any third party against the Company that relates to Executive&#8217;s employment by the Company&#59; provided, however, that (except with respect to any such action brought by a former employer of Executive that is related to such prior employment) Executive and the Company shall mutually agree in good faith on a reasonable rate of pay to compensate Executive for his time and efforts to assist the Company in any such defense.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.68pt">Inventions and Proprietary Information&#59; Prohibition on Third Party Information</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Confidentiality Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Executive acknowledges that he continues to be bound by the terms of the Company&#8217;s Confidentiality and Inventions Agreement by and between Executive and the Company, dated March 3, 2014, executed in connection with entering into the Prior Agreement (the &#8220;Confidentiality Agreement&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Non&#8209;Disclosure of Third Party Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Executive represents and warrants and covenants that Executive shall not disclose to the Company, or use, or induce the Company to use, any proprietary information or trade secrets of others at any time, including but not limited to any proprietary information or trade secrets of any former employer, if any&#59; and Executive acknowledges and agrees that any violation of this provision shall be grounds for Executive&#8217;s immediate termination and could subject Executive to substantial civil liabilities and criminal penalties. Executive further specifically and expressly acknowledges that no officer or other employee or representative of the Company has requested or instructed Executive to disclose or use any such third party proprietary information or trade secrets.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:16.36pt">Dispute Resolution</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.34pt">Executive and the Company (the &#8220;parties&#8221;) agree that any dispute arising out of or related to his employment shall be resolved by final and binding arbitration, except where subsection (6) below specifically allows a different remedy. Any arbitration proceeding shall be conducted in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association. Executive and the Company further agree that the following dispute resolution procedures shall apply&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">The parties shall use their best efforts to resolve any such dispute informally. If the matter is not resolved, the parties agree that the dispute shall be resolved by binding arbitration. If the parties are unable to jointly select a single arbitrator, they will obtain a list of five (5) arbitrators from the American Arbitration Association and select a single arbitrator by striking names from the list (each party may strike up to three (3) names and an arbitrator shall be selected from the remaining name(s), or the procedure shall be repeated until one name is selected by both parties).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">The arbitrator shall have the authority to determine whether the conduct complained of violates the complainant&#8217;s legal rights and, if so, to grant any relief authorized by law, subject to the exclusions of subsection (6) below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">Where Executive initiates such arbitration, Executive shall be required to pay administrative fees to the arbitrator not to exceed the amount of the then-current filing for a similar civil action filed in the Superior Court of San Diego County, California. The Company will pay the remaining costs of any arbitration fees, deposits and administrative costs assessed by the arbitrator. Each party shall pay its own costs and attorney&#8217;s fees&#59; however, the arbitrator shall have the power to award attorneys&#8217; fees, expert witness fees, and costs to the prevailing party to the extent provided by applicable law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">Arbitration shall be the exclusive final remedy for any dispute between the parties, such as disputes involving claims for discrimination or harassment (such as claims under the Fair Employment and Housing Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, or the Age Discrimination in Employment Act), wrongful termination, breach of contract, breach of public policy, physical or mental harm or distress or any other disputes.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">The arbitrator shall prepare a written decision containing the essential findings and conclusions on which the award is based so as to ensure meaningful judicial review of the decision. The arbitrator shall apply the same substantive law, with the same statutes of limitations and same remedies that would apply if the claims were brought in a court of law. The arbitrator shall have the authority to rule on a motion to dismiss and&#47;or summary judgment by either party, and the arbitrator shall apply the standards governing such motions under the California Code of Civil Procedure.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">The parties agree that the arbitration award shall be enforceable in any court having jurisdiction to enforce this Agreement&#59; however, either party may bring an action in a court of competent jurisdiction regarding or related to matters involving the Company&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">confidential, proprietary or trade secret information, including, but not limited to, any rights under the Confidentiality Agreement or regarding or related to inventions that Executive may claim to have developed prior to joining the Company or after joining the Company, pursuant to California Labor Code Section 2870.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:27pt">BY AGREEING TO THIS BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE COMPANY AGREE TO GIVE UP ALL RIGHTS TO TRIAL BY JURY.  IN ADDITION, BOTH EXECUTIVE AND THE COMPANY WAIVE ANY CONSTITUTIONAL OR OTHER RIGHT TO BRING CLAIMS COVERED BY THIS AGREEMENT OTHER THAN IN THEIR INDIVIDUAL CAPACITIES.  EXCEPT AS MAY BE PROHIBITED BY LAW, THIS WAIVER INCLUDES THE ABILITY TO ASSERT CLAIMS AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS OR REPRESENTATIVE PROCEEDING.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:10.36pt">Amendments&#59; Waivers&#59; Remedies</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement may not be amended or waived except by a writing signed by Executive and by a duly authorized representative of the Company other than Executive. Failure to exercise any right under this Agreement shall not constitute a waiver of such right. Any waiver of any breach of this Agreement shall not operate as a waiver of any subsequent breaches. All rights or remedies specified for a party herein shall be cumulative and in addition to all other rights and remedies of the party hereunder or under applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.68pt">Assignment&#59; Binding Effect</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Assignment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The performance of Executive is personal hereunder, and Executive agrees that Executive shall have no right to assign and shall not assign or purport to assign any rights or obligations under this Agreement. This Agreement may be assigned or transferred by the Company&#59; and nothing in this Agreement shall prevent the consolidation, merger or sale of the Company or a sale of any or all or substantially all of its assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:25pt">Binding Effect.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Subject to the foregoing restriction on assignment by Executive, this Agreement shall inure to the benefit of and be binding upon each of the parties&#59; the affiliates, officers, directors, agents, successors and assigns of the Company&#59; and the heirs, devisees, spouses, legal representatives and successors of Executive.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">Notices</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All notices or other communications required or permitted hereunder shall be made in writing and shall be deemed to have been duly given if delivered&#58; (a) by hand&#59; (b) by a nationally recognized overnight courier service&#59; or (c) by United States first class registered or certified mail, return receipt requested, to the principal address of the other party, as set forth below. The date of notice shall be deemed to be the earlier of (i) actual receipt of notice by any permitted means, or (ii) five business days following dispatch by overnight delivery service or the United States Mail. Executive shall be obligated to notify the Company in writing of any change in Executive&#8217;s address. Notice of change of address shall be effective only when done in accordance with this paragraph.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Company&#8217;s Notice Address&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ICU Medical, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">951 Calle Amanecer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">San Clemente, CA 92673</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">with a copy to&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Latham &#38; Watkins LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">650 Town Center Drive, 20th Floor</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Costa Mesa, CA 92626</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Attention&#58;  Daniel Rees</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive&#8217;s Notice Address&#58;  Executive&#8217;s most recent address on the Company&#8217;s records.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.68pt">Severability</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If any provision of this Agreement shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to the fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. In the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:15.02pt">Taxes</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All amounts paid or provided under this Agreement shall be subject to Annex A, as applicable, and paid less all applicable state and federal tax withholdings (if required) and any other withholdings required by any applicable jurisdiction or authorized by Executive.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:10.36pt">Governing Law</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement shall be governed by and construed in accordance with the laws of the State of California.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XIV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:11.02pt">Interpretation</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Each party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with legal counsel of their choice. This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Executive agrees and acknowledges that he has read and understands this Agreement, is entering into it freely and voluntarily, and has been advised to seek counsel prior to entering into this Agreement and has had ample opportunity to do so. Sections and section headings contained in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation of this Agreement. Whenever the context requires, references to the singular shall include the plural and the plural the singular.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:15.68pt">OBLIGATIONS SURVIVE TERMINATION OF EMPLOYMENT</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive agrees that any and all of Executive&#8217;s obligations under this Agreement, including but not limited to the Confidentiality Agreement, shall survive the termination of employment and the termination of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XVI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:11.02pt">Counterparts</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of which together shall constitute one and the same instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XVII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:6.36pt">Authority</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Each party represents and warrants that such party has the right, power and authority to enter into and execute this Agreement and to perform and discharge all of the obligations hereunder&#59; and that this Agreement constitutes the valid and legally binding agreement and obligation of such party and is enforceable in accordance with its terms.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">XVIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:1.7pt">Entire Agreement</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement is intended to be the final, complete, and exclusive statement of the terms of Executive&#8217;s employment by the Company and may not be contradicted by evidence of any prior or contemporaneous statements or agreements, except for agreements specifically referenced herein (including the Confidentiality Agreement). This Agreement supersedes all prior and contemporaneous agreements of the parties hereto that directly or indirectly bears upon the subject matter hereof (including any applicable term sheet or offer letter and the Prior Agreement). To the extent that the practices, policies or procedures of the Company, now or in the future, apply to Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In Witness Whereof, the parties have duly executed this Agreement as of the date first written above.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.884%"><tr><td style="width:1.0%"></td><td style="width:55.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.278%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.732%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ICU MEDICAL, INC.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VIVEK JAIN</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47;Brian M. Bonnell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47;Vivek Jain</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Signature</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">April 15, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">April 15, 2022</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ANNEX A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">SECTION 409A ADDENDUM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To the extent that any reimbursement of expenses or in-kind benefits provided to Executive under the Agreement or otherwise are subject to the provisions of Section 409A, any such payments, reimbursements and&#47;or benefits (i) shall be paid or reimbursed promptly but no later than December 31st of the year following the year in which the expense was incurred, (ii) shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided, in any other taxable year and (iii) shall not be subject to liquidation or exchange for another benefit.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Further, the severance payments and benefits set forth in Section III.D. are intended to satisfy the requirements of the &#8220;short-term deferral&#8221; rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations under Section 409A of the Internal Revenue Code of 1986, as amended. To the extent the severance payments and&#47;or benefits do not satisfy this rule, no severance pay or benefits to be paid or provided to Executive, if any, pursuant to the Agreement that, when considered together with any other severance payments or benefits, are considered deferred compensation under Section 409A (together, the &#8220;Deferred Payments&#8221;) will be paid or otherwise provided until Executive has had a &#8220;separation from service&#8221; within the meaning of Section 409A. Similarly, no severance payments or benefits payable to Executive, if any, that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has had a &#8220;separation from service&#8221; within the meaning of Section 409A. Each payment and benefit payable under the Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. In addition, to the extent that the payment of any amount pursuant to Section III.D is considered deferred compensation under Section 409A, any such payment scheduled to occur during the first sixty (60) days following the termination of employment pursuant to Section III.D shall not be paid until the sixtieth (60th) day following Executive&#8217;s separation from service and shall include payment of any amount that was otherwise scheduled to be paid prior thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding anything to the contrary in the Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of Executive&#8217;s termination (other than due to death), then the Deferred Payments that would otherwise have been payable within the first six (6) months following Executive&#8217;s separation from service, will be paid on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive&#8217;s separation from service, but in no event later than seven months after the date of such separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following Executive&#8217;s separation from service, but prior to the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The foregoing provisions are intended to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Executive agree to work together in good faith to consider </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">amendments to the Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">General Release of Claims</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You hereby enter into this General Release of Claims (the &#8220;Release&#8221;) on the terms described below with ICU Medical, Inc., a Delaware corporation (the &#8220;Company&#8221;). In consideration of the payments and benefits set forth in Section &#91;III.D.2 &#47; III.D.3&#93; of the Second Amended and Restated Employment Agreement entered into by and between you and the Company, dated March 1, 2022 (the &#8220;Employment Agreement&#8221;) and for other good and valuable consideration, the sufficiency of which you hereby agree to and acknowledge, you hereby waive and release to the maximum extent permitted by applicable law any and all claims or causes of action, whether or not now known, against the Company or its predecessors, successors, or past or present subsidiaries, officers, directors, agents, attorneys, employees, stockholders, assigns and employee benefit plans, with respect to any matter including, without limitation, any matter related to your employment with the Company or the termination of that employment relationship. This waiver and release includes, without limitation, claims under the Employee Retirement Income Security Act (ERISA)&#59; claims for attorneys&#8217; fees or costs&#59; claims of wrongful discharge, constructive discharge, emotional distress, defamation, invasion of privacy, fraud, breach of contract, and breach of the covenant of good faith and fair dealing&#59; any claims of discrimination, harassment, or retaliation based on sex, age, race, national origin, disability or on any other basis, under Title VII of the Civil Rights Act of 1964, the California Fair Employment and Housing Act, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act, or any other federal, state, or local law prohibiting discrimination and&#47;or harassment&#59; and claims under the California Labor Code, the California Business and Professions Code, and all other laws and regulations relating to employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You expressly waive and release any and all rights and benefits under Section 1542 of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Civil Code of the State of California</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> (or any analogous law of any other state), which reads as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You understand and agree that claims or facts in addition to or different from those which are now known or believed by you to exist may hereafter be discovered, but it is your intention to release all claims that you have or may have against the parties set forth above, whether known or unknown, suspected or unsuspected.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The waiver and release contained in this Release does not apply to (i) your rights under California Labor Code section 2802 and your indemnification rights under any indemnification agreement entered into by and between you and the Company and the Company&#8217;s internal governing documents, (ii) any claim which, as a matter of law, cannot be released by private agreement or (iii) with respect to your right to communicate directly with, cooperate with, or provide information to, any federal, state or local government regulator. If any provision of the waiver and release contained in this Release is found to be unenforceable, it shall not affect the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">enforceability of the remaining provisions and a court shall enforce all remaining provisions to the full extent permitted by law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You acknowledge and agree that, as of the date of this Release, you have been paid all compensation for all of your services with the Company and you are not entitled to any further money or benefits from the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">At all times in the future, you will remain bound by the Confidentiality and Inventions Agreement entered into by and between you and the Company, dated March 3, 2014 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  Notwithstanding anything in this Release or the Confidentiality Agreement to the contrary, nothing contained in this Release or the Confidentiality Agreement (a) prevents you from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that you have reason to believe is unlawful or (b) shall prohibit you from (i) filing a charge with, reporting possible violations of federal law or regulation to, participating in any investigation by, or cooperating with any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of applicable law or regulation and&#47;or (ii) communicating directly with, cooperating with, or providing information (including trade secrets) in confidence to, any federal, state or local government regulator (including, but not limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, or the U.S. Department of Justice) for the purpose of reporting or investigating a suspected violation of law, or from providing such information to your attorney or in a sealed complaint or other document filed in a lawsuit or other governmental proceeding.  Pursuant to 18 USC Section 1833(b), you will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made&#58; (x) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; or (y) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Nothing contained in this Release shall constitute or be treated as an admission by you or the Company of any liability, wrongdoing, or violation of law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You agree that you will not disclose to others the fact or terms of this Release, except that you may disclose such information to your spouse or to your attorney or accountant in order for such individuals to render services to you.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You agree not to disparage the Company or to say or write anything that portrays the Company, its products or personnel in a negative light. The Company agrees to direct its officers and directors not to disparage you or to make any public comments that portray you in negative light.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Release constitutes the entire agreement between you and the Company and any affiliate of the Company regarding the subject matter of this Release. This Release supersedes any other agreements, representations or understandings, whether oral or written and whether express or implied, which relate to the subject matter of this Release with the exception of the Confidentiality Agreement. You understand and agree that this Release may be modified only in a written document signed by you and a duly authorized officer of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Release shall be construed and interpreted in accordance with the laws of the State of California.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The provisions of this Release are severable. If any provision of this Release is held invalid or unenforceable, such provision shall be deemed deleted from this Release and such invalidity or unenforceability shall not affect any other provision of this Release, the balance of which will remain in and have its intended full force and effect&#59; provided, however that if such invalid or unenforceable provision may be modified so as to be valid and enforceable as a matter of law, such provision shall be deemed to have been modified so as to be valid and enforceable to the maximum extent permitted by law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You agree that this Release may be executed in counterparts, each of which shall be an original, but all of which together shall constitute one agreement. Execution of a facsimile copy or scanned image shall have the same force and effect as execution of an original, and a facsimile signature or scanned image shall be deemed an original and valid signature.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To accept this Release, please sign and date this Release and return it to me. You have until 11&#58;59 p.m. PT on &#91;DATE&#93; to review and consider this Release and to provide me with an executed copy thereof. Please indicate your agreement with the above terms by signing below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ICU MEDICAL, INC.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Signature)</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;    </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;    </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You have up to twenty-one (21) days after receipt of this Release within which to review it and to discuss with an attorney of your own choosing, at your own expense, whether or not you wish to sign it. Furthermore, you have seven (7) days after you have signed this Release during which time you may revoke this Release. If you wish to revoke this Release, you may do so by delivering a letter of revocation to Scott Lamb, the Company&#8217;s Chief Financial Officer, no later than the close of business on the seventh day after you sign this Release. Because of the revocation period, you understand that this Release shall not become effective or enforceable until the eighth (8th) day after the date you sign this Release.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">My agreement with the terms of this Release is signified by my signature below. Furthermore, I acknowledge that I have read and understand this Release and that I sign this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">release of all claims voluntarily, with full appreciation that at no time in the future may I pursue any of the rights I have waived in this Release.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signed _______________                  Dated&#58;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">_______________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Vivek Jain</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#929292;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>icui-20220415.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b01f3e58-929d-44cf-82e3-9cd911bcc09b,g:6cae09ed-1c74-4bf1-a1a7-eb31dc8be467-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:icui="http://www.icumed.com/20220415" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.icumed.com/20220415">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220415_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220415_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.icumed.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>icui-20220415_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b01f3e58-929d-44cf-82e3-9cd911bcc09b,g:6cae09ed-1c74-4bf1-a1a7-eb31dc8be467-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_d4e7c252-f42b-46dc-8c79-2183a857120e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bc95f04e-b8a6-4432-8a51-21ab317c1747_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_59b05fca-55d9-407a-813d-0ceb57f33a1d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1ee9e213-1c29-4a35-a8b0-e1afa40f7f92_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8f669783-7eda-4295-86e0-2e9045cd6e60_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_19dd5ce0-9ed9-441c-bb37-bc5f54da0998_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_afae2ccd-d95e-4ba4-8340-a1eaf15843e7_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_73a34786-8fa7-4748-bea6-7cb2f6d98f6a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8ef3820b-1e84-4138-9f1a-018cc21e64bd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_21c4c8fc-911c-454e-81a7-5eef5348ceb5_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_495928d7-6c75-4542-a915-7f27fd46425f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_8b88262f-fe4d-40a1-8124-18c8124bf315_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_78c85fc3-f71c-4e09-80e3-6bd6fe488689_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5fa59737-393a-4aa3-bcb8-9c5fb803bd68_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_80ef8aa0-9e59-45b5-a4f0-69d0eedc48c0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d8e5a548-3aaf-4349-a507-a783f0273784_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_90a51a94-0e30-4417-bdf5-1613711e6eda_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_328b2589-7e39-411a-be24-3ffe3a14e0e9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2e49eca2-e239-48f9-a2b1-1d091b01ce12_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_71e6dc09-b898-4765-92fb-1fc4a91e9e03_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6e520d0a-0e5b-4771-a20f-4235b28d2ac0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2da37a62-d97b-4db1-a849-9d3975f01a03_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9faaab16-8d59-466a-a554-0c031a8cdafd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>icui-20220415_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b01f3e58-929d-44cf-82e3-9cd911bcc09b,g:6cae09ed-1c74-4bf1-a1a7-eb31dc8be467-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/CoverPage" xlink:type="simple" xlink:href="icui-20220415.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_842c254e-ab09-4eb0-b0da-48f0a028a66c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_DocumentType_842c254e-ab09-4eb0-b0da-48f0a028a66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2ad550a2-f8db-4ca0-b759-731e9b688ec1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_DocumentPeriodEndDate_2ad550a2-f8db-4ca0-b759-731e9b688ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7af42b59-94dd-48da-a6aa-8b600fbc4b2e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityRegistrantName_7af42b59-94dd-48da-a6aa-8b600fbc4b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_cb358334-33dc-44c1-85e8-204aa3a5f6d3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_cb358334-33dc-44c1-85e8-204aa3a5f6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_490eae7f-44a2-409c-85c7-61a81274e3e9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityFileNumber_490eae7f-44a2-409c-85c7-61a81274e3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bc71feaf-1faf-4c6c-a647-58f57eecc9ab" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityTaxIdentificationNumber_bc71feaf-1faf-4c6c-a647-58f57eecc9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_58175fcc-6433-402a-8e0c-7829e13607d2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityAddressAddressLine1_58175fcc-6433-402a-8e0c-7829e13607d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6dccf96b-289e-4915-b8a2-67b5d9594b68" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityAddressCityOrTown_6dccf96b-289e-4915-b8a2-67b5d9594b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a1f6e8b8-1f3b-4809-bb3e-fe32b85f719e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityAddressStateOrProvince_a1f6e8b8-1f3b-4809-bb3e-fe32b85f719e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b4909e5e-6970-4ad5-9dca-246280b7fcdc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityAddressPostalZipCode_b4909e5e-6970-4ad5-9dca-246280b7fcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b7a6c385-d0fb-43ae-bd42-b0da40e841af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_CityAreaCode_b7a6c385-d0fb-43ae-bd42-b0da40e841af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5e92434b-b2b0-4d45-8dbc-940e0dcfe4ba" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_LocalPhoneNumber_5e92434b-b2b0-4d45-8dbc-940e0dcfe4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_6e9f8a39-d316-45bd-838f-b663df0977de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_WrittenCommunications_6e9f8a39-d316-45bd-838f-b663df0977de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_cc3ac309-00ec-41bb-bf7d-712d5226aada" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_SolicitingMaterial_cc3ac309-00ec-41bb-bf7d-712d5226aada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_796a97cf-5007-4e6e-9283-705abcce692d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_PreCommencementTenderOffer_796a97cf-5007-4e6e-9283-705abcce692d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_380ba7a8-7edd-4add-8ddf-e1699db00d77" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_380ba7a8-7edd-4add-8ddf-e1699db00d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b2bb40e7-c5f6-48e5-b6ab-32f555f8594d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_Security12bTitle_b2bb40e7-c5f6-48e5-b6ab-32f555f8594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b423e77f-6ac5-4a5b-b264-c4b3a102ed69" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_TradingSymbol_b423e77f-6ac5-4a5b-b264-c4b3a102ed69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f67e2371-f308-40ef-8a3d-b2a290f57723" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_SecurityExchangeName_f67e2371-f308-40ef-8a3d-b2a290f57723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_aa447b25-1580-42af-87d9-d073d087be93" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityEmergingGrowthCompany_aa447b25-1580-42af-87d9-d073d087be93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a80537f1-ed2e-4762-b30a-110a452f9872" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_AmendmentFlag_a80537f1-ed2e-4762-b30a-110a452f9872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0bf93fc4-2334-4a71-a818-5cd22df6acd3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_12e2d0c4-e2ec-412e-bb4c-8abfaaa36bb0" xlink:to="loc_dei_EntityCentralIndexKey_0bf93fc4-2334-4a71-a818-5cd22df6acd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139761159653816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Apr. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 15,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICU MEDICAL INC/DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0022692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Calle Amanecer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Clemente<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">366-2183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.10 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICUI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883984<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>icui-20220415_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="icui-20220415.xsd" xlink:type="simple"/>
    <context id="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-04-15</startDate>
            <endDate>2022-04-15</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM180L2ZyYWc6MTg5NGM2Yzc5N2QxNDExMDljNmM2MmU3YTdiNDA5Y2UvdGFibGU6YzllYmM0ODhkNzlmNGMwN2JjOTEwOTY1ZjI5NWQ2NjYvdGFibGVyYW5nZTpjOWViYzQ4OGQ3OWY0YzA3YmM5MTA5NjVmMjk1ZDY2Nl8wLTEtMS0xLTgwNzc3_d7195791-bf64-44a4-912c-aaa66e727eac">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM180L2ZyYWc6MTg5NGM2Yzc5N2QxNDExMDljNmM2MmU3YTdiNDA5Y2UvdGFibGU6YzllYmM0ODhkNzlmNGMwN2JjOTEwOTY1ZjI5NWQ2NjYvdGFibGVyYW5nZTpjOWViYzQ4OGQ3OWY0YzA3YmM5MTA5NjVmMjk1ZDY2Nl8xLTEtMS0xLTgwNzc3_eaac6acf-c2e8-4d63-a275-ff5842b7f307">ICU MEDICAL INC/DE</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM180L2ZyYWc6MTg5NGM2Yzc5N2QxNDExMDljNmM2MmU3YTdiNDA5Y2UvdGFibGU6YzllYmM0ODhkNzlmNGMwN2JjOTEwOTY1ZjI5NWQ2NjYvdGFibGVyYW5nZTpjOWViYzQ4OGQ3OWY0YzA3YmM5MTA5NjVmMjk1ZDY2Nl8yLTEtMS0xLTgwNzc3_abcf1d38-4590-4417-b292-41630defe589">0000883984</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl81MTI_3c1b4608-b220-4105-80cf-aade9c6a1889">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl8yMjc_5251e59d-7c5b-46e0-a294-d89c9b649da4">2022-04-15</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6N2E0MGIwODI1ODQ5NDkzOWFmNDA5MmE1OWUwYzYyOTAvdGFibGVyYW5nZTo3YTQwYjA4MjU4NDk0OTM5YWY0MDkyYTU5ZTBjNjI5MF8wLTAtMS0xLTgwNzc3_827c546b-11ae-461e-9134-489b7c81e2ea">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6N2E0MGIwODI1ODQ5NDkzOWFmNDA5MmE1OWUwYzYyOTAvdGFibGVyYW5nZTo3YTQwYjA4MjU4NDk0OTM5YWY0MDkyYTU5ZTBjNjI5MF8wLTItMS0xLTgwNzc3_141dbbb9-86d2-43f5-969a-e02b05c50345">001-34634</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6N2E0MGIwODI1ODQ5NDkzOWFmNDA5MmE1OWUwYzYyOTAvdGFibGVyYW5nZTo3YTQwYjA4MjU4NDk0OTM5YWY0MDkyYTU5ZTBjNjI5MF8wLTQtMS0xLTgwNzc3_d14c148a-8713-4803-b9fa-6e623f6b30c4">33-0022692</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTAtMS0xLTgwNzc3_3c777f01-5fed-4ec5-8fb9-8fcb52f8cade">951 Calle Amanecer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTItMS0xLTgwNzc3_507f8283-8f08-44a5-a19d-350ecf989292">San Clemente</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTQtMS0xLTgwNzc3_3486ceff-d1f9-4338-96e3-7c2682dc55da">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZmFjYWEyYjcwMWI5NDk2ZWFkMjEzZWMxZmY0MzQyNWUvdGFibGVyYW5nZTpmYWNhYTJiNzAxYjk0OTZlYWQyMTNlYzFmZjQzNDI1ZV8wLTYtMS0xLTgwNzc3_c7288030-39c1-4139-a214-af4a90edaba7">92673</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl81MTQ_c2a3f782-e98b-4fa2-9454-11bf31ec4d74">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGV4dHJlZ2lvbjozOTc0ZTgwYWRmYjQ0YTQ4OTZkYzQyNWYxYjJhZjM5Yl81MTU_1b49bf8f-64ad-4a5c-ad55-9b25a13f7f8f">366-2183</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl8xLTEtMS0xLTgwNzc3_4b576feb-7517-4d17-8f83-3ecfe4181c36">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl8yLTEtMS0xLTgwNzc3_b2ca1ca8-d5dd-4fe5-a75e-a08016aa4c9b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl8zLTEtMS0xLTgwNzc3_24c3f917-6994-4a6f-875d-323ffe77c287">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MmUyZjA4MGQwNGIxNGEyMDhhMDZiYTZmNWUyYWU0MjIvdGFibGVyYW5nZToyZTJmMDgwZDA0YjE0YTIwOGEwNmJhNmY1ZTJhZTQyMl80LTEtMS0xLTgwNzc3_987fc2dc-86f6-4e1c-9a5e-de5761087f2b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZjYwZjIzYjQyYTk5NGZjZjlhNTEzNzAwYWFlNTY3MmMvdGFibGVyYW5nZTpmNjBmMjNiNDJhOTk0ZmNmOWE1MTM3MDBhYWU1NjcyY18xLTAtMS0xLTgwNzc3_6e2b9e54-5dd9-4205-851f-e9f73e640303">Common stock, par value $0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZjYwZjIzYjQyYTk5NGZjZjlhNTEzNzAwYWFlNTY3MmMvdGFibGVyYW5nZTpmNjBmMjNiNDJhOTk0ZmNmOWE1MTM3MDBhYWU1NjcyY18xLTEtMS0xLTgwNzc3_590edd95-ed43-4d51-93ca-5063e09c7e2c">ICUI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6ZjYwZjIzYjQyYTk5NGZjZjlhNTEzNzAwYWFlNTY3MmMvdGFibGVyYW5nZTpmNjBmMjNiNDJhOTk0ZmNmOWE1MTM3MDBhYWU1NjcyY18xLTItMS0xLTgwNzc3_8ed502d6-e699-45aa-9e1e-0cd3839fb16b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415"
      id="id3VybDovL2RvY3MudjEvZG9jOjIxNmY3ODA0ODU3NDQwOTliODMzMmQyMThlNDRhMmEzL3NlYzoyMTZmNzgwNDg1NzQ0MDk5YjgzMzJkMjE4ZTQ0YTJhM18xL2ZyYWc6Mzk3NGU4MGFkZmI0NGE0ODk2ZGM0MjVmMWIyYWYzOWIvdGFibGU6MDQ2ZDk2YjgzNzg0NGQ1YjkwOTBlMDY2ZTcwODdkZWMvdGFibGVyYW5nZTowNDZkOTZiODM3ODQ0ZDViOTA5MGUwNjZlNzA4N2RlY18xLTItMS0xLTgwNzc3_bc4c180f-ddb7-41b2-9d93-0e56df5bec3d">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVVJW1]TUC,R*?>%"&MAE%J=KV-<S91^ ^TLIS:%AMYKE/P6C_P%02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4$L! A0#%     @ "8N45'MVH>?N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ "8N45)E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  )BY14@XG:\3$$   U$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ "8N45)^@&_"Q @  X@P
M  T              ( != P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  )
MBY14EXJ[',     3 @  "P              @ %0#P  7W)E;',O+G)E;'-0
M2P$"% ,4    "  )BY14&445]3<!   G @  #P              @ $Y$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ "8N45"0>FZ*M    ^ $  !H
M             ( !G1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ "8N45&60>9(9 0  SP,  !,              ( !@A(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  S!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="icui-20220415.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="icui-20220415.htm">icui-20220415.htm</File>
    <File>exhibit101_41522.htm</File>
    <File>icui-20220415.xsd</File>
    <File>icui-20220415_lab.xml</File>
    <File>icui-20220415_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "icui-20220415.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "icui-20220415.htm"
     ]
    },
    "labelLink": {
     "local": [
      "icui-20220415_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "icui-20220415_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "icui-20220415.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "icui",
   "nsuri": "http://www.icumed.com/20220415",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220415.htm",
      "contextRef": "i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.icumed.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220415.htm",
      "contextRef": "i252e5dae82ca40c888d94f6caa626e02_D20220415-20220415",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.icumed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000883984-22-000026-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000883984-22-000026-xbrl.zip
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MT]W#A[@/[PHVT R'7R(M3'2F\0#_8FKD<'VV_V%K^[_3S/KW)1I6ALF$JNS
MDPS5/,XR9!6USAN2$!,EXA:$?2AL\:\E*@XE<*/R0B<P5Y$'Y@G-<F-IR ^^
M?S37RI/IT5MD.S"$3$W>W.W,"1@@L+LH!<&5U-F5^=++(BY3?/F8_E"456ND
M0!^AIXT6,I"1885Q'BG[O:)W1N9I4J7P'W%3SXN2;A H0PVS0A:DP?6*$K@?
M<'PE'"E^I4R J:=L-\ &P9W2:1-GO(?Y#!DI"0+:I]Y9X6SA@.HK,T4D _IV
M'M=-J3HS)_YNUUI5<&MA!GEAI@U2HS-K4A"1_R^ 1$H-+^-QDA"I:M2\+G4-
M9A*\2D_Z3\%7=1FAZ(?QZ:12727SN)PIEAP@IM2LP,5>LV^KM845K#_@1O=<
M77BY/DSL$6X"7[,W:C%19377R[OE9(XW)$T)+ CY 5!;'"UH@D1.1W,@0OB4
MN0RT@DW60(_6C*1."F!0^3332;T;W24Y.6JR2C9SI,NX+%$59P[78X;R;XSR
M[ILZ RM#4]]:19[99<TD(E4)7!'6DJA^FQ>L 1"C,)RPS(8$;_A58?)Y44<7
MNLC0G$,)F*D9,6:5PR<21=9 ,0$:%5O";< "['@2<&@:PIML2XC\+P<XRPJ7
M6XH 0CLFR9J4Y!8^[XU*:T6F+G8B+J#4JH[+*QP ]F>J\4Z T(!1:/%F+]VG
MVQ_<Y M\O#X7V"JV,%9!ZI?S$>U&=WJ;S\5/<4O/4?]]NM2L,Z%='?.P@7NK
M9_G6QT5,8Z)F&KU8>:_>34Q&^PIW __-V-<RUR5:\#D\7E9T:?J4]V ^XUS3
M=3J'B>J<KY/OK![ ^)FJ8!OB,M.X7'D0V,JR*:L&N!U>U3/\ +P['H_)_"^F
MN]%X2GP%&"2PEJ9"#=R^S%I=WVX(1P)=N<#KG1 ?0I/B<\TN1_)8Y+",_>T(
M28S#B-$5S'!U>,8/OAG;XGFI@.'!MG3"<>:M25'#+)[ON5?B255D3;WZE1OZ
MM)\=X/\+B7J(VO ?)N4#G$DK%N?_[[QTRO!,[4Q*%7_:B:<PP^=Q=AE?53]]
M^XAEJ&E_[WLN5VH5R=/=@G^K&!W-S:12_VZ0'GLNU,HAMN1E^!^BUXH<9[&Y
M;:<J5Y?R7O>&:99?<0D6D,(0347W!VY750CY\W5V=T4N$# F>!)V%J4J/E*X
MH<AQ>(E69SX;X )X=IE<V"T[N9,BWY$)NJA2#:I 7,%1Z<\PJZW'>]L8]$+=
M OV]8E%GL8N%,2-2^8[HV;UWW&/X&RB51^LCE1_M/GZ"^W#<!/;SG9AHQTUI
MR+>/9KH^IU1=%#5[5GHE]P130?!FU3#/ :B#JIS!=;"__KU)9SRR]5.SW^,3
M"M@@_N'&5$#J:HI^=.NZ^J(B+OIW5Y4'!?="HTPCR1_Z.9QBC@(4;Y);_[0L
M0*W0V]8#)*QM@A8KN;-2W[>5P\V&3TUU#6KQ+,[U?WR%FY9 UQFY!'"9*%[B
MQ.(L,(0'\$'X(KGP$[V,D9]03&(>PVMH(8 %HR]T CN=-DG,8IG6.(7=EI^2
M8K%H<G)$E>C*@IL);#6>3L'TKEB]@<_ =V [XQE^HL>N07_4A1)-GVR!"SB6
M!5EAP"JS@GUBQ.AB5'S8/R6NQ7@&RMH,N75:T/X&[BKXYU2A0ZST?Y^(V<D[
MMO*$4?-AK1#-%4I( N:_+&HQ6BSIP9_!E&D2C4+%#/X=W%=K' )9HQC(X>[C
MI[@1>$]!AL<V#O(2> C<HOL;_UB1Z;0^6V_,Q)=QI:*S.(/[<;=2:;PBZNK'
M+R9*HAJ8?MAC%**S_PNRS;<KF?,O09]R'#^.*MJ,2.1$B:P%E3D4#=$<OEI*
M-@;]IK[:F>)K]1P,+_SM<9'!ZU6T]5]/GCP:P)YM(_MDH\GD"GE[;G. (C2.
MO3^XH, RUI@8 @PV*<J4A%];P%GV"/RV@;?1H52AJ-#5'.W'^*HL<*4E,NE$
M[?8PUMY/QRE>(%IOWA!_;I:7Z&W>FC0UL?2TN,SQ-]LH!U+%=J<+1TD(J+23
MM;<<?EB@$%2![.MD7G6?=SLVZF2+*<I\P7\[\X#7X [?7VA,8@P$:SY37AC&
MT*%B,P T]> M\CC@=C8ENOVJKHMQ,UQA_3QNW<(C?__;L_T7XYPT U1B@(C?
M$B6EN_"GPV^?#;&^1[5&80<CCL8Y.G/P3K\L\J:Z2XFT&[U"WS8RDB3.0.S$
MPL9%QG :3LLKJ4G[Y3S6KB'E='I%'#T7Q@KV!"PV6F8N)F9DE._[XR]V>7>-
MX=M:!BF6&(QGU=^9-L#5R/<!]D].3CTCR4 X)92HBQZG[7ZSRF=^/H,^Y^_2
M286"#.2,MRP48!B^@$G,88-9:\^*2Y+?,1L+_ECL>;Q0Y0[\E^3\3HPQ]PO>
M8\Q4\'+GO#A]09EO,'6P<$A&D@3H?4#4B453LV"C3"G0*I8@:]K"JU\0#4++
ME1<>+,.XJ+V,/#EO)Y1N(2G)P:3)],H4Q>U+A4]P9J4Q<0?1'';V D-"*V)C
MP1SQ7(1 4H66%,:Q<.^*IN_=.+U@#40L6!25Y&?R E6P,E!$%IB]:M-3ZGE9
M-#-66M"])E0^A448E[(E\ XYD/N8[4K0@%1I<E^ IVH,F%&R2Z)8?9M8"J+#
MQZ%WHR'0"O\!?A3]Q,NYO%YI;*EB\+6Y7K#N@.8*SB]&^W@"9"0J%L7QR.?;
M7C$M%6?':]7$,GA2Z#&I<9%Y$;$C I<M=X12WZ/]1ZUQ,*O/S/V:H3=9(5G#
MV-R0N<#HWPURZ2$JT-6Z!-K[M&#2>'G.BN>LK9R.:?9BCA%/7BXSN0$HT)!G
M%,NZFZ+VI5OG*-EF6E64]31#!R-'S84#\ 67J<F$\/6>5;6RHS%D!CN(G+S7
M&7<;CDR#2-C*8\^M'*]%G,K>NEPM]+353N2+F=8)TQ^-WH(4OU"9K)%%3I/5
M&CUH\J?^# 7G3"QR5CVNF#_R$=G9;7I<[^!'7&\UD_#L>W'QMC216UP==JUC
MP("N(OQWDV74.D6JR"LH_M>[%4JW#E2UE,*6N46!&UZ8L#WBQ4Z<Q!>QSDAP
M=;.I*PT+1,\:K !,!I1GGEC:LKE6K,2A1IW!&_A870RBAWO[6Y^V^:L##!/]
M&V2IGFK,&5-35:*03?Q[(D^22($)+$S9(A(J_O="<\0;!L&U54V):OD [V),
M6;I7E/\[Q0ULK?K[UANNV45[M48734+"'V*.X=VSH/!$<=Y?1B0>7<@J;NJI
MML\O"] 6J1P!J#/A?"[O9G7RY3D%OXI1<'!V.SD6K-?EAV#QS_7G]:'W0Z'W
MT6=D<W>=!''>B0.52B\F35DI/_Y/Y1=BW0-!E3&HV,!UBW1&O)X45*S3Y3NR
M4#'G,W!:D(U"*UDRFDU-63K]Z:89#3;>O<FT_,OZT?)K3-^.7JGUHV:,:N)_
M*<$\FBJIY.%2'V*K2=$ 368M+Z&KXN*\$?,346XEM;&YY+01=\_5K*AUS&EO
MJ:"[T \:Q(>2GVPVO:@GY Q-$K7D,*L7PFV6]#=@[)_UHJ%DX?_:W\-0JJE-
M#]QQ>>&[R3 U%_/G#DW^'#OA_ )=*=/BC].UUOE%H47TD%%LMNOO?WOXY 5F
MF/"N^5Y.\A>3%[EJ)J#HL?M@"18HY;OP+O#W6H5WI9I23B"F'EWSL=;"CE7"
M!32'^PR L>%)+.N3Q;+_;'?O@+QZE&"^]^S%1_3[^VGGZ)_W4U@Q0&W__"/'
MY9N[6U<<S)I4RO550+3U9L?T)/86FS5AD$F";YBS@D^ATEN1-I*S3@^_EZ1G
MQ\ \[TPPOJ_4VS*"6TX6YX%F,Z6#FF 2_4'"1YA$C>8J.Y:O1,?".>6%^8$7
M@]9RC4-4-?!(*68"+H_KL@ 7H)=Q>A^J8JQ=X<"E)H@R,@AHC8BB0=F+ S8[
MI,#6.%P[]<GLWW2?4IX]A%XOO<1SI:T,;S?ZA"7VA6+C_5+RVE@:$=OWWAAP
M:JU7H.7K@E9R7EL.(]7A&+\#M?0S"59,B\%3O]25<BFP#$JQR8KDNJ6H^**A
MY7D"TH+?'*NXGM]M+L3-_0-?+NARI97]0XE)[U5 >0RE"ROT] 6E:!,7.HH;
MH/4M2D:;&E[@U4SMOI*< 7*W93IT4IP06\+I^$?B(>A,5%9<;DN&MF%L],V!
MI%.+8<?QVY9J/8^Q$/K8NNBNG><VGOV6OH AOU MUV&_P!B\O4L9+()F]7FI
MP^S*WLC;EE<Y&OFE--M]F8.J'2AW4B.L+:/<BAX3%XG[2]' W14F#BRL.V*U
M+.A$V.V)N=_"Z!E':< Q^W\WNG112<9/ZK7!*8TC1MNGJLLF\4*9[*<JRA4%
MC>9K^57HW,6R'3H6<A5@_'XWBLY<8-*G@^-=2EL$F4BBHT=0W$8T["*)SZ6@
M@!XSWY)B0':AX5"B!YB,F^[R@$&4M*NIN@ !XQ!&Q-M<F7+AT$<M64X&#,F+
M%IOWOKUHVI!@YN&]"&:NBU:PAMF0+<7 WL%-5@6D!#-1;;\*.8<&3M11=D5;
MU4;9B$;'SXC!=LJ&QK52>&!QEV!65[=5%399RU[#O"L3UF95Q#NXN[U0XS^K
MX'TYD<HSLGLM#*>D;DEV4$*6I*VI6(6SLA*TP4ZPPNF6)LJ-KET.X8DCXPQS
M54DQ".$0NLX)0C_)BVC:E*0Z.#T(1UW$GQ0;\V3G!IIA*U5WQ7B,6^XEDZ*2
M,B$45HXIAFSK"A50KH7$/32DY6SO[XJYN Y\H)^^]^_0S=;B Q2SZ3<DO M0
ME(/0C(/K1(AI:*CT2;>ULC>VB32'25(BP-%;SU:XWMI$)H.K!M-D:S^,GN"G
MPVN*FR3X!@)70DPBKHS ]I?KJ?A9?%EMDS]\@R_$P9I=B/'T!G63MQ-0'O,G
MGT>IJB:K)?(VSB_ :LH);<I7GJZGSRVV%RD8%D='XR/_7987^<!/[^W.N,_E
MXQO3K8\>[SX4B)TO9K\PHH!)QC>R8-,Y_U:\O3:4?K![(^8?1UFS6 (9+8QT
M)U]A7,TQO3S.S&%7')C>^KQ-U53DVP>%(H-?[>\^VN803/"DWB8A$M12Q5ZU
M6*07F.4'=X;*2#S4EU7W!3^:Z@HQ%DH+\U8B)H1)Q/(_1@K<9=%D:30C0#T,
M"O1>$ZL'.4=>RV3:-O@1V_VU6[8:!=U3_HPKV V:*4HXKT[ 2X.9%7'&N0JM
MASS;RNIH-HB^>@I8,8".B@B=;Q6E7 9%QGBT5K@%71ZVKK8%LP/[0F"M7%$:
MWVD/<\&!_(5,NG-!@"!;XM22J$6""1:@1% %EN",2!U=J_KMVITCI=56N855
MV29K&Y/GX)T<_6\6OL-]0@<ON?S8:1@S=/J/RG60M>>"?DR<ED7">BA:IHD*
M>O>Q7A4G9R4>#F.'3R/8J+RAY @$9$&]1<29K0!K>^(OX\K5IH4HQ'AH'7K8
M]=VS0]BXS]%03)2 ?BS3,*5_E&&,%E6$H4C4@ Q[D8DCWI-6((RV'N_5<U*[
M6F5=(9TXATEKJO:3%B_ _^2.S]'DTUPK;TC2KT250AM3[G:C,V_1B=WZ&U6U
MP?H-R'Y0:NOSQ'!76L_=X&)9D2^7BI8O6B^7PK#BTT4Q\""S>\HO-\/'LT+"
M3]9)PG,:S@@KMOU:L&B&4+&LJ#D68+H"_2L&N@?YR&E5>W2]VLE6^\P_-$GT
M? <8F\U&8"4"89&0/*8-_+ EGDCAMNA(L<BIWIN&JH*ITG=PM(II&DF-$O&H
MF,'"3\65YO!**!@ZTL##4??(&M6.\.%+1&*2P2C:2A(3KR3)5:X3-T^#+@Y+
M&. 83A*A]0OZM3(PZOB[;?:SD>5JL#H8E8GO^JE"S+MKP[6@@P/S'><6@'*P
M&H:L;W.KND@^1<52.G-(HB_7)KN)MKW&> !8C\O8HDMK$-5S;*>Q=;A-7*?Z
M J.^AN_AXR:_L2:,PH=/7GC160-C0NS*27M>QVX4$8VS0;3I0:Z']R+(=4?\
MN<.N0J:SPSH4LYZYREIU\0Y6IR52+5.II1?DBJ(/CW3Y&_%F(>2L$)K).@E-
M,HO/VE71Y+T3Y[9),4C5(,A%(=AP16!3#*(Z5W%6(UI*J0QLL@F+(?G,E,U/
MZ.J3L[)HEF8$KL[SH4_XE1PXD>;F9F\7N9Z _ONR2='P.P7ADR<ZT_S!84+R
M</_9TT<6=>OH[<O3H1=?"#A^RSY X 2OD#!%9%AV,?7$)6R./+H2T'F,J@)&
M @3Z=;"RM(2FA,GI"]TLVB7K_;B8M)54-KA41,F51&RB>%$TL!)???4M)#+Z
M3"$@E8J3=<@> >Z<@K<5+_,7PE'S.!7($-P.+S+K?ZYG!-D.W^<A#Q^+N/,]
M>A[>MO$Q"R5Z:!H+H+)YJ/WO/]WAW_; "?=:!B83-@WR7$6=\>@ 3X?I4P@\
MH.G81S(VJ/Q>KHREZ]#[0 3 'E=G:V)P.4AY9?>B )8.R)>D6:&D$;L8063/
MV) 4V7(F_5,3V#%5AU)*4 MBN)LBYM2?_CM-8"R8<PJKKEVD3'B_[2T$[,-J
M=@_WG@UEW\XQ*MG $9T2=!W]V3RVOXL/[NQOQ=M;C[8'G! G/B<O%.IR7!LI
MTRJ"-DDT4^]D^<.X,3U,QS@NX';!;TU&51C"\!/DS/-4[2O9O&;^!T_V']M$
MNV8"(T2_\+?.&-20^123WSMXF6"<RZ*6]Y$##!$"-Z4O'^$YPAO6V8WWB-.Z
M.5CKF(#U51)\%2N\OOBW#,E/VW-99A[4C<<3<R)QH,F:L5KY(W39J$ (_I1E
M(C,N#)OW")R"1BQ>S'R,1ZUF/_N&E";WJP6']SHL1#6.)?8H1.=1.S[SK<,S
MG-,+1EML14/5]LE5T@Q8F&+0##,<]V 53.CJ]((J,(7%1+WU-$B$)"9:BWG&
M$W%%)P3-UIFFW2=GB2Z*5$^%\?Z(0*U?!,J=,1XQ!9 Z!^L,K%)157S:<]*<
M^2Z*1'U91%L'/^).]SSN1*D1\L./ALD__?/AFLE$NH"ZQ#X=Z.F2LGW_2D^^
MSGTFU%I% +4Q&S:A'P?7N?.2#"X?1>X63AP6FLHY$O^XRQP>ZGC,V^W'ON")
M^F/N;X[FW,P%_L-%_RU=],*S-KO?S*/UR7@F;B6'=[?)S4.!Z26I2M8IPA%>
ML5/8UX0QUN*ZC)$R4#FWQ8H>:,1=X<WP5X=RIXJ<6YJ9[P7>RU1EY!]JUQ&0
M>E,H[@E5JHOB$S5:,O%M+ I6PB^2+-8+8@/3^*)HMR4.=?M-C],\^A&GN0Y^
M=:XGNHZ&@8XH]]=/0@%I;5BR2T0DDI:N%$+5J&U2UVGNTD-%Y];T1J).Q"X/
M)(3- FYW(?,"G4ZMW@QGS?T ;!Q]!F6+FC6=@JJ17K'Q<%)$;X YS#;HN.Y'
M#4(71\CT)>OW$J$[&X,*I@(N$'=\TUO0RPAOE'FM=%!AE9P[[%'?#?^N".':
M.@7.$C2/MD&@S*->YMYU,:1M6U67P[3JIE82?#!43)#)J%F71,ZVAJGU#?1L
M>)&IL,H'_?XY-8F6[HYQ!0=(#G?2)I37S)@^HS%S$3LQQI>BT?,^#3I(S#U3
M45U8F0V\:.M6V]#.VY=6![8\!0O'F$,R!4K\1&Q!FS!IZ[NNOXD(5E.:4GJ+
ML-T=A&:0-HG4QZ"%&9<8$ E+R5I!:2RM,:5I%M.&R;<JFC*Y!N@RV!E2FKX&
M)-B*@4*4L/VG/\!>GS\1O, C1HN,CL641K?J-7@'7PW);7T9QKI)YF$5-95%
M21H85;RGGLZ ;B',UH] R_H%6I [>H&(@>F/9)%'Q!E!7!9S6BB?1?K#D$8E
M9XYYG";GY4I)W@O%QWV@''D87VQR^JN%.,:@#-8),7/'1(X>?^P/=_]ZII-W
MTR4$4,G+@^OU3>W^+%C6;>S?P#W_!:JXH6S8WWOZ5Q0.ZZ9-KA .! !FQ %K
M?R@4?LB$=;K-H3G@YYU6%6(89PQ\E5(=U;1A'.]2+3G!>1KKK"F5X/UZ25 2
M="%+%-MESW)"Y*C)EN1D//,N9]Y%P 4D_J=7XA7'ML%:JA8X$2ZILA\.(D,$
MKT%F08NWV%P\[L<B;<&0++#U1"55"%0&&*10\N,3E6&LJ6H!V.$2>K= ]:6K
M\DZP;-ODJ["&@JW'/Y//XIDR1<]P#0@['/,?&LY3Y,NRT)7YG9!4Y;=P9R_T
M CT[)?7$T_GO3:F+IAUI^4$5ZU<(T)>5EU_H1+Q<E(.[S%2,'I*<TVPQKHX]
M;N)HJK*"$87B*"D1JQ.1U;,+!N&-FW0089+ ?_Z3"=0[Y\M,!2&[N*:8:0.(
M(5TG8EC%(O2"BSX"28FUL%E1H8P+(Z ^$4U9\&!_/<JB7)9:46J9SDF2L2\9
M-2MVFWF#)C&5)!/FS)PRR;R.FQ-./4TD6X6>W8Y0$%,:)-4K@'P.6<]FJ]7K
MEFF\2JVFONPHBHY@T++(?JC8]T#%YIRL?S>:TQ+8P>WU8!XP<,Z5Z!/-,MJR
MNK"RF/5>#MW^(;!&K+F%%_8?XK\/MEU*&VC3FEKDC#XG3"^V]NOP(2=F+[!0
M*LR^]!\VX?7MC4_1>/PC1>.ZJV:(YYTJ*^RZ+5 Q0&L6^ V$VR684]5<+TT,
M*8F7NH8_2"5ZF"&DL7;!]03P[LV ?\/?\CZ C7DNL3R@_]*<-IF"&Y/N'**,
M7339C,Q75W?I4_YV] A3",MH4;#HEFJB+<FO[@,[*$WSH,4"4:/[%N5?M+<]
MV91'_.X9ONMVT:OM@L$G%!ZY*&JN$KITU7^=2<E#E6,%K?GX0%WPL-_QT<#\
M26DBX<=0-6=15E]<QP?^L.-!01;WRH;L4XX_ U,P4]65ET(\:-5S>#11>4%,
M+W(>1SV2TJ#B4UJ QXZ[2):T[>W'VBB]#&[?\Q1ML'2Z"/I,DKK&G=MAYTNX
MN]L(E)A7!;H_D.AB;?IU="%)&3,=-JFTP+JXKJSS\,#"Y*^8G#^*[ZB-L9M;
M7L62Q$"&+%<@*:X"-%4\22;JI]ZVFY7*AK22OY-M=Z#\.V/9;+*.LH:^#Z>.
M5)C!/?"RY*D,V-25M?)3%I3C;A]E/YG/)L9Y@D!4L,ICPT8LA\-J6[*$0SA>
M+E:U=QEKL[$9./8_^[TH25'ROG8]:V&0(K,T3O?F+@Z&J_E5RF(2>0O&O:A\
M=HC]>&R2"T4SS)_:73@,+!0R]7F1I;A-EUP6!Y.51 =FOR@85R^S9PNY\!Z;
M^DRG6#7K)<QCV@Y7(#.R9/O=:$OP>"7!2DM*<55XO!33IJY,6H^W?[P;.M=D
MMMJE$Z*EW5 I(N_"7 K,%/DX""8#.9T=Q'A.VIE%H3BBQ"33E-Y))A?#[/M&
M1:V-7+,[6/!G :1%2J/LL@EQ6=(L"+40IVR4#0]HT]+=]@]&MH[N.M:6\JI9
M+%QO0Z"9HIR!2O@?R?%=J!(S@.7\&4*#*_6,=ZXM?:,JYJH6IH545\:&H2]D
M1')A%,"K><4\N[JCACD%^J7IBWI$BE[,@M( <S1Y!G\;K,!^(ZVX;X"!U#)-
M6_H38S9Y17PHG$U)GJ<G?6%-OL2@PBE4*DE5F!=<FT-5/VU#P+S^)3V8QKR1
MDME?K[ER6SJFPV!%A\\!6P%T[1])9=$M; "#2OAG=?<_J*P/# \%@QS7(A]D
MADRV4<G*(=6S^SJA0?_KW;PMO^,H)WMX'>U\S(<X&%0@%4.9P+TH/*63#+G6
MU5M)@&U)*Y=,3#;_3('BBV8V)V!:8]SAL#IE9/+M+9K)3?;F.N#^H7WER+UB
MM9T.6H3%H$'?+\,^T*FQ$P6'9R!=XCBFS[<NG4$]N"7E#[[^W6M3&5D#>6$$
MYQ;E+UO$EMX-,L;-C6TFSTQ"\K 65-=F6OG-[:[_8#47:+D$_H ?H'<.9*<9
MC,\_;]_3J?ND:O6\+JP3/>O\,NJSKJA<TJ]U[R,@W]#KZJDM6V!"MD"HI5VS
M'2PR^G1=J0.@5G<&\(C#, Z2QZBDL>N:['8W3OQ'27L;B,5@S(^5=^;/:GF/
M'MY_+6\-XW!L1,4.5,2WLEIJ%FF Y,A0(#TS#<276LX#BAQYH#T"^6)$;$.<
MWT_6T/G]+8.1=W2]O@!MAN6(77>FYR%!E<I45#"L:E]MCJVB"O(T4;IZ&.[^
M@]O]K1-)?HBWQ>%[I*03\75L-79DE."JV\N1(,\"*,504OD5*?%%H5F;UHO
M[G+ET77\&2;$<[[F$RA(?(6SE#V#U22EGG Q?XA(0Z!# _9EEA%PP\X&^U4M
MU^QP+9A>?BWV]5[K'M>X0U1WF/'A]W6/8@U&6M&B&5%:$_M-\2CSA@QL!^T
MYN &X'2'8#QN/=IHX+)U VE9E4X00I)UDPFNZTU#-UM<?1XHFF C3M1,YQR"
MRP6+S!@"[4KJ0.LT,,]]=X&=#&GOH'2O+XL=!AKJXEQ>,^XF$^KWPN?XDX3J
M&D0;&@6*\?^6J;2'>KO)6J!Q$421C?DA]LT.619^_G!OK2XG[G8[.R&+WG^Z
MQYYD4VAK>C%P!G/H]0"JC9=Q@I:3%$X@WY8TL/E5A<VA,=>43!&;3^I!X;!W
MOR[P'>H HG#>TG$PEC$T;$!%GJ%>TU@36 \FDY65J>T!:]&@A7KE&&7/7G >
M;*F6L"J<._YQD^_1X_MQCSS@N)[K@A1"#+W$.^*<>CW]^"057X(G XL4)=;Y
MA>D!F>@2['E4;1$$,T!_L4'D>-OZY[;4MG2)[07\=9,S'^2&>Q=23.Q_3;)%
MO%>"<F<7)_,4,+\%+N:A!)*I!Y$Y0@50$Y"=>&+[>^ BRE_8KAB?M_JC":VN
M7@R5&5"1'?(KBN"7?+'#^G[[F)<-:M5QE=I :U94%8>_TG@!!ESEN3YI.L@?
MP\"JYSAB5$+2]&D:W>"GK^#:4&)MD>+Z=ZG=A+B[:]?G-GZUBN[U93-KF-R(
MIVU*':(4+9+&!!%6B=!!%#? 64I)><1[ '=0DX#7E%9BU3J0,&@[T;_"I[9-
M=VMM4&7;R4Y J\!T*H:M(.+L:I0( TXPU$BB99PR6CO"@50H"G4UQ^BQ&WH1
MEY^ B?6EF@7,K<],VM]]^NS)SO[68MNVT+XF?L+7Q=58P34J=%Z',(:\*JU\
M$*^WE!%0=G<A;,T2\M(5VX. >9[R,K 3"G'Y6^CB!)U/2G?GN+F"K'7>"5PR
M(,Y2(X(V _$9& @_]Z!"A'!,W>!U)[1NY?04MVX\/\FHY:4!A^E+Q=_LIJOK
MF(44.UX2P.=V68E7Q[[Q![E^61BQWS#%XQ3,SSG9T,2JO*M;NB"@AUWNA("-
MT)D8E4T V^3C7\?PC+O'XE]L*8A;G%-CA)-!W:,B*&K9+=(U$U@^# *R*>R!
M#+#%7O5P!Q@E3_0251*VVEN-.ID"<]@!^P'CJ?8ROEWZQ^%>!%N'XQC'P8TF
MQLEU7YC*ZA@^;QW#$O,W6 Y7W,S2;O&F!ZJ>KF&@:FW"2T!]):%C]FODL68;
M<=$(AQ6+<PLN[&5,&I3Z'&/L=,#ZV'6C8;X*OL3CT:7ON4,,?3_A/#VP+3'&
MXU'S'YNP3<>4A/1  +68CX46!)7_0J&=:O\T,2D 6]_E\F\S(_)JQ6>4M%IZ
MZ1JYBX2M9A7>:G]D+/QS2ZV32.S:R<B&L!U5RRL[;05;VXCQ&@'V)=Q)J:M
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M[>O68+F3XFVJAUD!1%WM,])+A3]UV'->^*ANH>;.H)\^='3;&D <6XD5LXL
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M4LQR,J\XUH-2'=WN&B?&W0)<<^Z$!GB?DSOSK*8D&\9G2S*XWNBKU%6M9*W
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M[;KJ8_VM^*0B ,C1#K#)%':.57EB7_O\;"DR$Z;,=E-LNK3Y_!2D9E/FF-"
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MK&;?#R9%>@7_F=>+[)__'U!+ P04    "  )BY14X];;.;D8  !9K   $0
M &EC=6DM,C R,C T,34N:'1M[3U9=]K(TN_W5_3'W9QSW* 523CQ/<1@#YD
ML8WC@9><EKH%PD)B)&' O_ZK;@G,9@<[WN,\S%CTHNK:J[JZ]?%_DX&/+ED4
M>V'P*2?GI1SZW_['_\/XK\\G7U$E=$8#%B3H(&(D812-O:2'SBF++Y ;A0-T
M'D87WB7!6(PY"(?3R.OV$J1(BK+2&)5L2795IIO84BR*-<UQL:DP%5L.M639
M=AS)LG>[I:)#F&0QBF7'T+!FNS(F,C$PLU69.J;-M**Q2TN*7'0-4]),W= T
MR;)L4U45JL@FTS2B$)6_MI? ZF"%05SR)LFG7"])AJ5"83P>YR=VY.?#J%OP
M M\+&%]N(8E($+MA-" )H*, BY"PI&!9R6633*#KQ=(T8U5,(EN651"MLZZ4
M>?..XETQ<_+=\+( #7QF.3<';#-<BB2K"\#-08!V[Z81$A\1)R1PV*S_&L3+
MW7FS36)V#4V" =*E$3/(;\.4K&/)Q.I\59/8VX0G>*=<^*O^]=3IL0'!*\#>
MC%E.2-&IY).@^RG' GQVF@,",T+W/PY80A ?BMG?(^_R4^X@#!)@6]R:#F%N
M)WWZE$O8)"F(J0K[__C'/SXF7N*S?<\9>9@SK*3)^L="^N/'0CJU'=+I_D?J
M7:(XF?KL4XYZ\= GTU(0!@P \"8EWI%%Z9\>I2P0?T)[ V0G\IST_9/DA+F?
M<IZB*TRGA)F*0S3),4V36IH+/$^*2I%)RH_*#)0Y3#D4D %_-?-*91!'RD7R
MT"?='/(H3$G5[U.[$EY^54XNVVI]1/O5R\Z1U6_V:Y/&H*TV*V6I63E3&Y7C
M<;/E>\U*_:H^.)[66SV_43GIU0?5JZ]JPV]?A?!;9]"XZHX;E:[<N#J6ZI4+
MO=WO7M6OOES4^U6MTSJ6VJTOO;IL2E^5SK1][A3KK:[>.*HK[2M';RC'DT:E
M.JE7_'YC4%?J@S.UW:)>HU+6V\K9)3TZ].RCLV+[RO?;@SK U;MH7/D#&#]N
M*%_ZS5858&S+G7Y-;YP?*XU^.QOS'=ZE!YW6L-\\_^ZUKXZUYM&QVCQO2^VK
ML@ISZ?5666_TOP_J_0NY4VDK#=\<?VU5D_JI-/G:@C5=.>H/:LB6;E@RMMTB
M:!>-:-B2%0<3($"1&8K!B)/;=XD?LX^%)3H^)EFK ;#=](1UO9B+5M* EG?J
M_HRZDS7J,D*<(@'#XBC,Q!HMJI@HAHY=5S<UQ39<53)R^[6#,U2O5FH'Y:^H
MUC@H5*I/3NH#$.&(^+6 LLF?;/I.ZY_1>KI&:V([KDQ5(+-N22#)LH%MQ5*P
M)A=5B3(7/ TKMR_!/]-4+5-;HW%A66-',"1B8(WB#8:&V\E2+*P6< $2IKZ4
M@'GYE(N]P=#G)DS\UHL$DRS:E/PDIC!%87F.]/W7+\U@B,-1))Z$H2]EG)>R
MQWTX;S81$VPW>_(H?W8]%B$!$-MH\ ]J?RXC<'7P_NRGY=F'@-^0SI[ Q$=)
M!=S'?0X4EC3,S>QJVQQ,>D/76<OL>?:2PA*B9EB=H[&P8*$+8,=38YZB\R<>
MY \YMS@F<P &7H![C'NY)4W)&_HPV1M[-.F59$GZ=TYTW?\8#PDPE1T58(+T
M[W2>M=DXS)CX7C<H.8!$%N72P;-V)_3#J/1/2?S;<V&1V"4#SY^6_MOR!L"J
M#39&)^& !/_=C<$G ^<M\MRT8^Q=L9)L H#B<9P";< \W(^;+4)6.-AGC5JK
M6D&GK7*K>KH,\PN$]K1Z<'92:]6JIZC<J*#J7P=_E!M'5730K-=KIZ>U9N,9
MER!MM83S\ND?M<91J]G8197\01Y")EVS[@SV)B9[TM4J6ZWV/_^4B]+>8?.D
MGO[UB/9U%K.FOO]SFM7)W*Q>7:B-HS.M?G1XT1G4)&!5>-^%TCFJ2W5NYLYK
MT*]]U3RO@8G\KM$_OO@=Q;^T^^%5L^5('3!Y[?.30;O/YP9SV>I<@-F<-L[;
MDW;_2Z_3K^MMWY3KK=H/U9%MK0BQF VH 5LHZ=B4P"$BH (M\(UDDUM%$_^Y
M:@[1Z^.][20-5,5)M=%")]5OS9/66UWEMU$4CR!R0$F(3IG#PW(DJZAY@F1]
MAWY H8N2'N--H\A+/'AQ=>+TP,=AJ.PDO%FV5.WU8T?;B!WN.? UGK!A&"5H
M9_;,"/@.+$X0N^1IKD@T,_IAMJ#GH"1Z N7X33A/U=2ERJ$TDP/33Y(2A5_P
M -[9X\,P)5,\!31A%OQ>VG1:[SL_=$67F6Y1;#BZC37 ,,23EH:I:3F67=0L
M2K3<?GD8>3[(V:[(>[X!Q5K<BE$7PNA='D?G7^%*MU,?.]4) 27)!8)KC6B>
MIT$D1O&0.3P:HL@+D)?$"-0J*)'HPXW+&I"H"U%$$@Y+/'S8M,J$V#Z;];?#
M".(7#*OUR3!FI=D?>[-D9)J9Q6+07C:['29).! ON&11XCG$SUXBWI<V9Z&+
M9A@BDN$OAC@IH;,W9Y%-7A)MA81N:-2,O*+?TG[KX%L;E<>:6#/STKT'OWR0
M"X*(T:S'G)53 E.P*#[GS$\Y-3?K,R24>D&WI PG2-[$DZM,-/ H]=G3.SMI
MD/W8Z;E:X(01^ )B>^,T 9-X$(Z"))H>A'397O+=$I[&2-@P"B_Y/*_44*;9
MO(92E>I'M7&S4I.;E6.]4;F ]L,!S_H!/'+S_&S<OFI/FZWR2C8O5,&8CMO]
MLE;OGVDP3FJVP)">MSFLTW;K3.^T/O<;_9I>/^1Y^?)R-L]4P,1J11O+,F%@
M:66&+5G5L&9:MN&8,E,8 3^.^61,HO74_$S59K)Q"X=+G+]S6W5]%P8A#(>>
MSV!V&PS3.V/_G+%KRXPM:S*U;=O"9I$J6%-='5M%BV# OBWICBZIFLZSK#)6
MM:*Z(4O]SMF/QMDM,JEER6Q'J/IW-M^:S8]7]E5ES0$GA6#3D%70VI**;<LE
MN,B*BNH6;55R(%)252P!-8K66I2TQ.>;'1A5NI\#XS-WS0=.W=_<)K=\P7'>
MPE%_XG!$R,6.\$A0&*$PZ;$(]4>1%U-/)'U^%G2\_-5!@.4MNE\?5L+*MZT)
M;Z#X03@8>#&OTD+<'*-447UX,NOP]F2H=G**JH.A'TY9]/J%9MF,H4:8WR@V
M0K$61)Y@RW3+TR8B5*LX"W/OGHB0I,>*ZA]K8N,1(38>)0]1-!YIXD>#6):5
M[6=^V,R)J(6]46N^28^Z3&G$XCC[WU< 0'[%WG1G<-AOGU>G[;XSAG;N32N=
M\T/^CJO.>7W2&8!W++8.SE9KFP;M\T8/8/ :5^5)N\^]Z8[?/N?KX6LX''3Z
MQU<-\-([WS=D0U3', P78D+=911KS-&QZ?(8TG5L77%-AU!P12Q=1@?$!_U<
M!LY@#C=D]XX>MW:$GI6!=W]M1;^O1![ G\VH%8Y?<W;RZ>1Q)8FC2X9K*J8*
M BB9O&I8QT2V*%9UB3FN95J*I>3V3X%]#GS&-UA_)4/YTD*21Y'$30'%VTXV
M98(H8O=F]"T*+SUQ].'M;B8\G;BN)*-4S2PZS'4QE5T+:ZIJ8JO(5&PX2M%4
MJ*,#,7/[8#H]0'[@D?>DZ]/+P;<0&-WO>,-T2^V=R7_*Y.UE)G<,Q30E5<*J
MY<A8DU4+$T76,'$U8DF,$IL8X",J14.]1[)5UM9B'D[,%\[2-^1Z,I;CM1O#
M"+2N-R0^8A/FC!+ODI=TN)[#XJ?+IKU$'($D(BZ*']:9XTX)HQ=9UK.Y@&GG
M$74=][?+$2.O5KO]2AGR\0]'(:IKF IFEFECS24*MC1=P[)LNZK,'(T:&B@G
M7O&^K)H^/&;YX]<0I.U;+PQ>\W[VKQ#F[(=L:Y;MFBXN:H1B"&0<3*BN8\M6
M="(#S: MMZ\6BUB1S37#<?<*OZ<NU;L^0_G?&"7,9T-.;A0(>N_RG25_Q-4R
M(B"<P%R4O=6BQ4:A_.)AW#F$X(=%665E)&(A>"2IO09RN2@M4J<HYM$2\DD\
M*]-^1?65NBSG]?MN:SQ67EQ]I+T'S;I#*G^S\ZFL.Y_6"T\J;/:J#GK,N1 '
M+\@00GIP/OG&O1U.D,W\<,SYFS=R*4 F_A.YGL]UDQ>#HDI80('ODQ!8?S#R
M$Q*P<!3[4Q23Q(O=J1B9#0AM6&NZ]9<=]%BH41[!/"!3P736Y@)_AV,^CJ<9
M/+ZK'*.=F#%TQ (6@6]<"V#L*#U%4LXK^13<#Z5M @=]B\V2A]^,OBN9RT *
M'YT%'C<!J'[Z:W1^1)_E//(28 5> # *LOW=>#UK9(>A;Q.@:P+<]2K]FC2<
MK@_.IAU>A'1T/&X< 9Q'U6F]TNO5*QVOS6$X/X,Q9S"^MEK -.VTO@SJE>ZX
M ^MJ]ZL 3VW</*J.&X,O/5BO#.T]@'-:WW1U@&;K1M%E-C9TV< :A?^8KJEB
ME3DNTV13=M0B/\AH&9JV][#9W1>GMC*>@V4L,AT:+IPQ.QF!_=04/=,N*V?+
M^)&R'=E !X<G2%&E/'3<$%>^ZXY'UAVGH>\Y0)&@6P>[PZ%^5QR_J#C6[Z&P
M@3:R0TQ,=0H1E<MT3 R=82*9DEPD1',L^W=1'-<,AP89QZUK#5DC6%86%,?2
M2=2YVM"D?-KS77,\O>;X%C'N<?";2<1A>NZ+1DW7Y3F3=PWR2QKD:DV#*)JC
MNA8X'$7+TK!&BBXV#9UB55$!XX;A**;QNV@08#SL+'#>3WT06:-8V;$_;*=/
MTK[O&N79-4HMCD<L>M<K#Z=7I#6]8IF&ZRC4P6;1+6*-R0ZV"'@FE$&H(TO0
MJOPVGLG=]8K*L+;C;*=7LKY/M7?F!;S<6]R6]-#HM+;*VRZ$>FFBB46,+N%P
M?@>)T,U9X@GP5GH]65M+R9MJ\=\W)VW_?5.*4]7R1<V\L1D8YL:VVZ:5K;RI
M:0\^K:;D%6D[:#-3^39J25O\IM?T%ABGAQR?Q/&;JY=M143L=IU.!W;HO[GE
M-;(;.00%V4P]@]H9]SSXY5HW;>'P;=AT +1$X3C]6\FM*!ZNJ !#*(:8EZ+9
M6E\J_IX^]Y2:B*FLV$+07K$#U^FWQYU^[:K=/YZV6Q=ZXZC3[_3]7J-5O6I<
ME<?M\T._T8+5#.IK)5Z-_N=!O=_P&I4OO6;K0@*(!\WSJEQOU=5ZY7,/'#^Y
MT7>F;0[CZC& (E-LB^D:UBFUL*;PR]QTV<7,<@V5%35)E=3</G>K0\XZH7.Q
MBX8D0I?$'S'T+]#<$AKR.SY[=[PSX9WK[\GUF;Y-U>T[RV_!\BLQB\Y+%ZFE
M8T8U%6M4E[&E.@3K4E%EDN483''$U5.U>P0L[SQ\%\T]"W?2R\A7HW-N;5]_
MA?J3L?G*@1*345U2:!&SH@6:72<$6TQF6'*H:JJ6:\M%",U;$#,U2$S)W^B4
M:W=4)]$%2]#7KP?W*>F]+:/UAD1CY\@/;>)#".I#$)KA[%=#\R>^D,V4[G\A
MVV,5#"G:8YU6-A_M!CGMD9 !>O-7[V-3U\5QNPK[%Y=;JP64Y]$8LJ?($15/
MP/(7$(,Q<3W)2CF2%R, D8':ZO+(M N^9M+CZ;@A+U$B,:+,A5>(ZQ27G]*:
M TG?<)GM]1VV*MKA=TP;>Z+N8-;9$]<R#OFUC+S.,,WP*396MKP8=SXIS_9=
MCUN8-O]V]A0>E#FJ-Q#ZX?/+=S4ZKV;K)#TW-4/DD<#C08K&-[QK4CE6.M"'
MSPWO@S''<KM_ ?!]]NN5MM)I.>-FA5YTSE==LQ!@ZUPT6QV^#EC;L=2I?/>:
MK;)>/SH;-_H='UP[K:&<^!M=,]O1'-F47$RI;6!-MA5L44O%$M.+U-5MYJCT
M(79-[B#G2UTWJY99>?']7BDKOZQ;[G!KSG.9*?<6P\./!FRT8MY:/6T/K))P
M+<$J!:'8[1C%3/0"7&55N_P#:9[8 4D_5,+E5+S+G_*7BP_I<348P-J@)6*7
M7@SCP-:1P.%ZB3@.OW*4=^8?2:,DHG%:KTMOVFI1=\A\JV71B.717-L^BVJ<
MR\K*SL\MWTFYV4G?:I=LY0,MPS"E12EB/N%'_M8^V7+MV0N>E:Z'$!MBH5&R
M/N1G7WFYZ]=FC-QL3"^Z%L8NPW;$R 4F+G@9)>*/R33.%1[ADS2W(W;++^9(
MN;49G_I47RUA Z3G)06)?U4_$P\0C(H7P4,8[:'R<!AZ02)V@J'A )0: 0^S
M*4Z"1O$>XO:5!3&!WE-4CB(N2[QWO*G['3C[AJU<M?@$:O$G^,JC"AN2*!E%
M;!%9,==/W^;'9J]1M FS\1IJUT?F7PFZ-F]]-P.T?-__+A(7X3-N/7QX")P\
MVN$J^#__-,&7V\L\-?$D[WU (J,@ AK0W0"_^*0C/(..1R=,W/Y LYOI! [+
MW8BE)0O":'P']76!OG#V6WS+;)9- V>OWA6680$>V=B+T4'/8R[8B]EIZ(Q,
M><2S3[=-RR,YYKJ<"6 8$9)1)Y'30W**&;&DL>?[PAOV@A%#W*+Y2[T BZ/
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M;SIJ+FYRN3IO9YQR_OW5O.<I2P*4(9;;2*0,B1@.@M@0+6,^!&K]OU=[17!
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M+FAT;5!+ 0(4 Q0    (  F+E%3CUMLYN1@  %FL   1              "
M 194  !I8W5I+3(P,C(P-#$U+FAT;5!+ 0(4 Q0    (  F+E%2M5AVA;0(
M '4'   1              "  ?YL  !I8W5I+3(P,C(P-#$U+GAS9%!+ 0(4
M Q0    (  F+E%39:F]2>@H  $E>   5              "  9IO  !I8W5I
M+3(P,C(P-#$U7VQA8BYX;6Q02P$"% ,4    "  )BY14;.^@KJ@&  #D,
M%0              @ %'>@  :6-U:2TR,#(R,#0Q-5]P<F4N>&UL4$L%!@
0   %  4 1@$  "*!      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
